<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Adjuvant chemotherapy for resected early‐stage non‐small cell lung cancer - Burdett, S - 2015 | Cochrane Library</title> <meta content="Adjuvant chemotherapy for resected early‐stage non‐small cell lung cancer - Burdett, S - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011430/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Adjuvant chemotherapy for resected early‐stage non‐small cell lung cancer - Burdett, S - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011430/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011430" name="dc.identifier" scheme="DOI"/> <meta content="Adjuvant chemotherapy for resected early‐stage non‐small cell lung cancer" name="citation_title"/> <meta content="Sarah Burdett" name="citation_author"/> <meta content="MRC Clinical Trials Unit at UCL" name="citation_author_institution"/> <meta content="sarah.burdett@ucl.ac.uk" name="citation_author_email"/> <meta content="Jean Pierre Pignon" name="citation_author"/> <meta content="Gustave Roussy Cancer Campus" name="citation_author_institution"/> <meta content="Jayne Tierney" name="citation_author"/> <meta content="MRC Clinical Trials Unit at UCL" name="citation_author_institution"/> <meta content="Helene Tribodet" name="citation_author"/> <meta content="Gustave Roussy Cancer Campus" name="citation_author_institution"/> <meta content="Lesley Stewart" name="citation_author"/> <meta content="University of York" name="citation_author_institution"/> <meta content="Cecile Le Pechoux" name="citation_author"/> <meta content="Gustave Roussy Cancer Campus" name="citation_author_institution"/> <meta content="Anne Aupérin" name="citation_author"/> <meta content="Gustave Roussy Cancer Campus" name="citation_author_institution"/> <meta content="Thierry Le Chevalier" name="citation_author"/> <meta content="Gustave Roussy Cancer Campus" name="citation_author_institution"/> <meta content="Richard J Stephens" name="citation_author"/> <meta content="MRC Clinical Trials Unit at UCL" name="citation_author_institution"/> <meta content="Rodrigo Arriagada" name="citation_author"/> <meta content="Karolinska Institutet" name="citation_author_institution"/> <meta content="Julian PT Higgins" name="citation_author"/> <meta content="University of Bristol" name="citation_author_institution"/> <meta content="David H Johnson" name="citation_author"/> <meta content="University of Texas Southwestern Medical Center" name="citation_author_institution"/> <meta content="Jan Van Meerbeeck" name="citation_author"/> <meta content="University Hospital," name="citation_author_institution"/> <meta content="Mahesh KB Parmar" name="citation_author"/> <meta content="MRC Clinical Trials Unit at UCL" name="citation_author_institution"/> <meta content="Robert L Souhami" name="citation_author"/> <meta content="Cancer Research UK" name="citation_author_institution"/> <meta content="Bengt Bergman" name="citation_author"/> <meta content="Sahlgrenska Academy" name="citation_author_institution"/> <meta content="Jean‐Yves Douillard" name="citation_author"/> <meta content="Integrated Centers of Oncology R Gauducheau" name="citation_author_institution"/> <meta content="Ariane Dunant" name="citation_author"/> <meta content="Gustave Roussy Cancer Campus" name="citation_author_institution"/> <meta content="Chiaki Endo" name="citation_author"/> <meta content="Institute of Development, Aging and Cancer, Tohoku University" name="citation_author_institution"/> <meta content="David Girling" name="citation_author"/> <meta content="MRC Clinical Trials Unit at UCL" name="citation_author_institution"/> <meta content="Harubumi Kato" name="citation_author"/> <meta content="Tokyo Medical University" name="citation_author_institution"/> <meta content="Steven M Keller" name="citation_author"/> <meta content="Montefi ore Medical Center" name="citation_author_institution"/> <meta content="Hideki Kimura" name="citation_author"/> <meta content="Chiba Cancer Center" name="citation_author_institution"/> <meta content="Aija Knuuttila" name="citation_author"/> <meta content="Helsinki University Central Hospital" name="citation_author_institution"/> <meta content="Ken Kodama" name="citation_author"/> <meta content="Osaka Medical Center for Cancer and Cardiovascular Diseases" name="citation_author_institution"/> <meta content="Ritsuko Komaki" name="citation_author"/> <meta content="University of Texas MD Anderson Cancer Center" name="citation_author_institution"/> <meta content="Mark G Kris" name="citation_author"/> <meta content="Memorial Sloan‐Kettering Cancer Center" name="citation_author_institution"/> <meta content="Thomas Lad" name="citation_author"/> <meta content="Cook County Hospital" name="citation_author_institution"/> <meta content="Tommaso Mineo" name="citation_author"/> <meta content="Policlinico Tor Vergata, University" name="citation_author_institution"/> <meta content="Steven Piantadosi" name="citation_author"/> <meta content="Cedars Sinai Medical Centre, Samuel Oschin Comprehensive Cancer Institute" name="citation_author_institution"/> <meta content="Rafael Rosell" name="citation_author"/> <meta content="Catalan Institute of Oncology, Hospital Germans Trias i Pujol" name="citation_author_institution"/> <meta content="Giorgio Scagliotti" name="citation_author"/> <meta content="S. Luigi Hospital" name="citation_author_institution"/> <meta content="Lesley K Seymour" name="citation_author"/> <meta content="Frances A Shepherd" name="citation_author"/> <meta content="Princess Margaret Cancer Centre" name="citation_author_institution"/> <meta content="Richard Sylvester" name="citation_author"/> <meta content="European Organisation for Research and Treatment of Cancer" name="citation_author_institution"/> <meta content="Hirohito Tada" name="citation_author"/> <meta content="Suita Saiseikai Hospital" name="citation_author_institution"/> <meta content="Fumihiro Tanaka" name="citation_author"/> <meta content="University of Occupational and Environmental Health" name="citation_author_institution"/> <meta content="Valter Torri" name="citation_author"/> <meta content="Mario Negri Institute" name="citation_author_institution"/> <meta content="David Waller" name="citation_author"/> <meta content="Glenfield Hospital" name="citation_author_institution"/> <meta content="Ying Liang" name="citation_author"/> <meta content="Sun Yat‐Sen University Cancer Center" name="citation_author_institution"/> <meta content="for the Non‐Small Cell Lung Cancer Collaborative Group" name="citation_author"/> <meta content="MRC Clinical Trials Unit at UCL" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD011430" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/03/02" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011430/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011430/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011430/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antineoplastic Agents [therapeutic use]; Carcinoma, Non‐Small‐Cell Lung [*drug therapy, mortality, pathology, radiotherapy, *surgery]; Chemotherapy, Adjuvant; Combined Modality Therapy [methods]; Lung Neoplasms [*drug therapy, mortality, pathology, radiotherapy, *surgery]; Randomized Controlled Trials as Topic; Tumor Burden" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011430&amp;doi=10.1002/14651858.CD011430&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="i9CklieH";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011430\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011430\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011430\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011430\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","pt","hr","fr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011430",title:"Adjuvant chemotherapy for resected early\\u2010stage non\\u2010small cell lung cancer",firstPublishedDate:"Mar 2, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Lung Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=i9CklieH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011430&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011430';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011430/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011430/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011430%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011430/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011430/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011430/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011430/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011430" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011430/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011430" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011430/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011430/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7559 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011430" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-sec-0084"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-sec-0036"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-sec-0041"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-sec-0042"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-sec-0068"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-sec-0076"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011430/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/appendices#CD011430-sec-0089"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/table_n/CD011430StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/table_n/CD011430StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011430/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011430/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011430/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011430/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011430/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Adjuvant chemotherapy for resected early‐stage non‐small cell lung cancer</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Sarah Burdett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0003">Jean Pierre Pignon</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0004">Jayne Tierney</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0005">Helene Tribodet</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0006">Lesley Stewart</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0007">Cecile Le Pechoux</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0008">Anne Aupérin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0009">Thierry Le Chevalier</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0010">Richard J Stephens</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0011">Rodrigo Arriagada</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0012">Julian PT Higgins</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0013">David H Johnson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0014">Jan Van Meerbeeck</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0015">Mahesh KB Parmar</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0016">Robert L Souhami</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0017">Bengt Bergman</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0018">Jean‐Yves Douillard</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0019">Ariane Dunant</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0020">Chiaki Endo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0021">David Girling</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0022">Harubumi Kato</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0023">Steven M Keller</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0024">Hideki Kimura</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0025">Aija Knuuttila</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0026">Ken Kodama</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0027">Ritsuko Komaki</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0028">Mark G Kris</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0029">Thomas Lad</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0030">Tommaso Mineo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0031">Steven Piantadosi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0032">Rafael Rosell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0033">Giorgio Scagliotti</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0034">Lesley K Seymour</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0035">Frances A Shepherd</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0036">Richard Sylvester</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0037">Hirohito Tada</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0038">Fumihiro Tanaka</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0039">Valter Torri</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0040">David Waller</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0041">Ying Liang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011430/information#CD011430-cr-0042">for the Non‐Small Cell Lung Cancer Collaborative Group</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011430/information/en#CD011430-sec-0092">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 02 March 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011430/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011430">https://doi.org/10.1002/14651858.CD011430</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011430-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011430-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011430-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011430-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011430-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD011430-abs-0002">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011430-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011430-abs-0001" lang="en"> <section id="CD011430-sec-0001"> <h3 class="title" id="CD011430-sec-0001">Background</h3> <p>To evaluate the effects of administering chemotherapy following surgery, or following surgery plus radiotherapy (known as adjuvant chemotherapy) in patients with early stage non‐small cell lung cancer (NSCLC),we performed two systematic reviews and meta‐analyses of all randomised controlled trials using individual participant data. Results were first published in The Lancet in 2010. </p> </section> <section id="CD011430-sec-0002"> <h3 class="title" id="CD011430-sec-0002">Objectives</h3> <p>To compare, in terms of overall survival, time to locoregional recurrence, time to distant recurrence and recurrence‐free survival: </p> <p>A. Surgery versus surgery plus adjuvant chemotherapy<br/> B. Surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy </p> <p>in patients with histologically diagnosed early stage NSCLC.</p> <p>(2)To investigate whether or not predefined patient subgroups benefit more or less from cisplatin‐based chemotherapy in terms of survival. </p> </section> <section id="CD011430-sec-0003"> <h3 class="title" id="CD011430-sec-0003">Search methods</h3> <p>We supplemented MEDLINE and CANCERLIT searches (1995 to December 2013) with information from trial registers, handsearching relevant meeting proceedings and by discussion with trialists and organisations. </p> </section> <section id="CD011430-sec-0004"> <h3 class="title" id="CD011430-sec-0004">Selection criteria</h3> <p>We included trials of a) surgery versus surgery plus adjuvant chemotherapy; and b) surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy, provided that they randomised NSCLC patients using a method which precluded prior knowledge of treatment assignment. </p> </section> <section id="CD011430-sec-0005"> <h3 class="title" id="CD011430-sec-0005">Data collection and analysis</h3> <p>We carried out a quantitative meta‐analysis using updated information from individual participants from all randomised trials. Data from all patients were sought from those responsible for the trial. We obtained updated individual participant data (IPD) on survival, and date of last follow‐up, as well as details of treatment allocated, date of randomisation, age, sex, histological cell type, stage, and performance status. To avoid potential bias, we requested information for all randomised patients, including those excluded from the investigators' original analyses. We conducted all analyses on intention‐to‐treat on the endpoint of survival. For trials using cisplatin‐based regimens, we carried out subgroup analyses by age, sex, histological cell type, tumour stage, and performance status. </p> </section> <section id="CD011430-sec-0006"> <h3 class="title" id="CD011430-sec-0006">Main results</h3> <p>We identified 35 trials evaluating surgery plus adjuvant chemotherapy versus surgery alone. IPD were available for 26 of these trials and our analyses are based on 8447 participants (3323 deaths) in 34 trial comparisons. There was clear evidence of a benefit of adding chemotherapy after surgery (hazard ratio (HR)= 0.86, 95% confidence interval (CI)= 0.81 to 0.92, p&lt; 0.0001), with an absolute increase in survival of 4% at five years. </p> <p>We identified 15 trials evaluating surgery plus radiotherapy plus chemotherapy versus surgery plus radiotherapy alone. IPD were available for 12 of these trials and our analyses are based on 2660 participants (1909 deaths) in 13 trial comparisons. There was also evidence of a benefit of adding chemotherapy to surgery plus radiotherapy (HR= 0.88, 95% CI= 0.81 to 0.97, p= 0.009). This represents an absolute improvement in survival of 4% at five years. </p> <p>For both meta‐analyses, we found similar benefits for recurrence outcomes and there was little variation in effect according to the type of chemotherapy, other trial characteristics or patient subgroup. </p> <p>We did not undertake analysis of the effects of adjuvant chemotherapy on quality of life and adverse events. Quality of life information was not routinely collected during the trials, but where toxicity was assessed and mentioned in the publications, it was thought to be manageable. We considered the risk of bias in the included trials to be low. </p> </section> <section id="CD011430-sec-0007"> <h3 class="title" id="CD011430-sec-0007">Authors' conclusions</h3> <p>Results from 47 trial comparisons and 11,107 patients demonstrate the clear benefit of adjuvant chemotherapy for these patients, irrespective of whether chemotherapy was given in addition to surgery or surgery plus radiotherapy. This is the most up‐to‐date and complete systematic review and individual participant data (IPD) meta‐analysis that has been carried out. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011430-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011430-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011430-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011430-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011430-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011430-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011430-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD011430-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011430-abs-0014">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011430-abs-0005" lang="en"> <h3>Chemotherapy after surgery for early stage non‐small cell lung cancer</h3> <p><b>Review question</b> </p> <p>Do patients with non‐small cell lung cancer live longer if they are given chemotherapy after surgery? </p> <p><b>Background</b> </p> <p>Non‐small cell lung cancer is the most common type of lung cancer. If the tumour is early stage, not too big and has not spread to other parts of the body, doctors usually operate to remove it. At the same time, they will also remove a bit of the lung, or the entire lung that has the tumour. They may also give radiotherapy (treatment with x‐rays) after the operation, aiming to kill any remaining cancer cells. They may also give chemotherapy (drug treatment) after surgery to lower the risk of the cancer coming back. This treatment is called adjuvant chemotherapy.<br/> <br/> In 1995, we did a systematic review and meta‐analysis of individual participant data looking at adjuvant chemotherapy and surgery (with or without radiotherapy). It brought together information from all patients who took part in similar trials. These trials compared what happened to people with non‐small cell lung cancer who were given chemotherapy after surgery (with or without radiotherapy) with those who had surgery without chemotherapy (with or without radiotherapy). We found that it was not clear whether chemotherapy helped patients with non‐small cell lung cancer live longer.<br/> <br/> Since this study was completed, many new trials have been done. Therefore, we carried out a new systematic review and meta‐analysis of individual participant data that included all trials, old and new. This study aimed to find out if giving chemotherapy after surgery (with or without radiotherapy) can a) help patients live longer, b) stop the cancer coming back (recurrence), and c) stop the cancer spreading to other parts of the body (metastases). </p> <p>We carried out two studies called meta‐analyses that included patients with non‐small cell lung cancer that took part in randomised controlled trials comparing: </p> <p>a) surgery versus surgery plus adjuvant chemotherapy; and</p> <p>b) surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy.</p> <p>Results were first published in the Lancet in 2010.</p> <p><b>Study characteristics</b> </p> <p>We searched for relevant trials up to December 2013. The studies brought together trial data from all over the world with 26 trials (34 trial comparisons) and 8447 patients in the first meta‐analysis (surgery versus surgery plus adjuvant chemotherapy); and 12 trials (13 trial comparisons) and 2660 patients in the second meta‐analysis (surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy). Trials were carried out between 1979 and 2003. </p> <p><b>Key results</b> </p> <p>Results found that people with non‐small cell lung cancer that had surgery followed by chemotherapy (with or without radiotherapy), lived longer than those who had surgery without chemotherapy (with or without radiotherapy).<br/> <br/> After five years, 64 out of every 100 patients who were given chemotherapy after surgery were alive compared to 60 patients out of every 100 who just had surgery. For those who also received radiotherapy, after five years, 33 out of every 100 patients who received chemotherapy, surgery and radiotherapy were alive compared to 29 out of every 100 patients who received surgery and radiotherapy. </p> <p>Quality of life information was not routinely collected during the trials, but where toxicity was assessed and mentioned in the publications, it was thought to be manageable.<br/> <br/> In both studies, there was little variation in the effect of chemotherapy according to the type of chemotherapy given, other trial characteristics, or by the type of patient included in the trial. </p> <p><b>Quality of evidence</b> </p> <p>These systematic reviews and meta‐analyses use individual participant data, which is considered the gold standard of this type of review. We included all eligible trials if possible, no matter what language they were published in or whether they were published or not.  The first meta‐analysis (surgery versus surgery plus adjuvant chemotherapy) included 92% of all patients in eligible trials and the second meta‐analysis (surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy) included 86% of all patients in eligible trials. </p> <p>We are confident that further research is unlikely to change the findings. The studies were well designed and conducted, address the review question, and the effects are consistent across trials. The impact of any data we have not been able to include in our analyses is small. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011430-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011430-sec-0084">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011430-sec-0124">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011430-sec-0084"></div> <h3 class="title" id="CD011430-sec-0085">Implications for practice</h3> <section id="CD011430-sec-0085"> <p>The addition of chemotherapy following surgery and postoperative radiotherapy gave a 4% improvement in 5‐year survival from 29% to 33%. This benefit should be balanced against possible toxicity and quality of life. Where toxicity was assessed and mentioned in the publications, it was thought to be manageable. This 4% increase does not seem to vary with the timing of chemotherapy in relation to radiotherapy, extent of surgery, or by patient subgroup (<a href="#CD011430-fig-0006">Figure 6</a>; <a href="#CD011430-fig-0009">Figure 9</a>). The lower survival rates than those in the surgery and chemotherapy meta‐analysis are most likely because patients with stage III tumours predominate and the incomplete resection rate is higher (<a href="#CD011430-tbl-0002">Table 2</a>). A previous meta‐analysis (<a href="./references#CD011430-bbs2-0080" title="PORT Meta‐analysis Trialists Group. Postoperative radiotherapy in non‐small‐cell lung cancer: systematic review and meta‐analysis of individual patient data from nine randomised controlled trials. Lancet1998;352(9124):257‐63. ">PORT 1998</a>; <a href="./references#CD011430-bbs2-0081" title="PORT Meta‐analysis Trialists Group. Postoperative radiotherapy for non‐small cell lung cancer. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD002142.pub2] ">PORT 2005</a>) has shown that postoperative radiotherapy has a detrimental effect on survival, particularly for early stage tumours, but old radiotherapy techniques were used. </p> </section> <h3 class="title" id="CD011430-sec-0086">Implications for research</h3> <section id="CD011430-sec-0086"> <p>This meta‐analysis was not designed to study the effect of postoperative radiotherapy, but has shown that the effect of chemotherapy is similar, irrespective of what locoregional treatment is used: surgery alone or surgery plus postoperative radiotherapy. Randomised trials are needed to assess whether modern radiotherapy is effective as an adjuvant treatment. Since this review was completed, we have found further eligible trials (<a href="./references#CD011430-bbs2-0059" title="FelipE , RosellR , MaestreJA , Rodriguez‐PaniaguaJM , MoranT , AstudilloJ , et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early‐stage non‐small‐cell lung cancer. Journal of Clinical Oncology2010;28(19):3138‐45. ">NATCH 2010</a>; <a href="./references#CD011430-bbs2-0055" title="WangS , OuW , SunH , YangHX , FangQ . Adjuvant chemotherapy in completely resected stage III‐N2 non‐small cell lung cancer. Proceedings of the American Society of Clinical Oncology2009;27:A7563. ">Wang 2009</a>; <a href="./references#CD011430-bbs2-0060" title="ZhengS , JiangS , LiH . Adjuvant chemotherapy following radical surgery for non‐small cell lung cancer: a randomised study on 70 patients. Journal of Thoracic Oncology2011;6(6 Suppl 2):S866. ">Zheng 2011</a>); (see <a href="./references#CD011430-sec-0100" title="">Characteristics of studies awaiting classification</a> and <a href="./references#CD011430-sec-0099" title="">Characteristics of excluded studies</a>) it is hoped that we will be able to include these trials in a future update of this project. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011430-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011430-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011430-sec-0102">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD011430-sec-0036"></div> <section id="CD011430-sec-0037"> <h3 class="title" id="CD011430-sec-0037">Description of the condition</h3> <p>Worldwide, around 1.5 million new cases of lung cancer are diagnosed annually (<a href="./references#CD011430-bbs2-0077" title="ParkinDM , BrayF , FerlayJ , PisaniPaola . Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians2005;55(2):74‐108. ">Parkin 2005</a>), and approximately 85% of such cases are non‐small cell lung cancer (NSCLC).(<a href="./references#CD011430-bbs2-0062" title="American Cancer Society. Cancer Facts and Figures 2007. www.cancer.org/acs/groups/content/@nho/documents/document/caff2007pwsecuredpdf.pdf (accessed in December 2009)2007. ">American Cancer Society 2007</a>). Although surgery is regarded as optimal treatment, only 20% to 25% of tumours are suitable for potentially curative resection (<a href="./references#CD011430-bbs2-0067" title="DattaD , LahiriB . Preoperative evaluation of patients undergoing lung resection surgery. Chest2003;123(6):2096‐103. ">Datta 2003</a>), therefore other treatments are also used. Our previous individual participant data (IPD) meta‐analyses (<a href="./references#CD011430-bbs2-0075" title="Non‐Small Cell Lung Cancer Collaborative Group. Chemotherapy in non‐small cell lung cancer: a meta‐analysis using updated data on individual patients from 52 randomised clinical trials. BMJ1995;311(7010):899‐909. ">NSCLC Collaborative Group 1995</a>), gave evidence that cisplatin‐based chemotherapy after surgery might prolong survival (hazard ratio (HR)] = 0.87, 95% confidence interval (CI)= 0.74 to 1.02, p= 0.08). With fewer trials and patients, the value of chemotherapy following surgery plus postoperative radiotherapy was less clear (<a href="./references#CD011430-bbs2-0075" title="Non‐Small Cell Lung Cancer Collaborative Group. Chemotherapy in non‐small cell lung cancer: a meta‐analysis using updated data on individual patients from 52 randomised clinical trials. BMJ1995;311(7010):899‐909. ">NSCLC Collaborative Group 1995</a>). Recent meta‐analyses (<a href="./references#CD011430-bbs2-0064" title="BerghmansT , PaesmansM , MeertAP , MascauxC , LothaireP , LafitteJJ , et al. Survival improvement in resectable non‐small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta‐analysis of the literature. Lung Cancer2005;49(1):13‐23. ">Berghmans 2005</a>; <a href="./references#CD011430-bbs2-0065" title="BriaE , GrallaRJ , RaftopoulousH , FerrettiG , FeliciA , NisticoC . Does adjuvant chemotherapy improve survival in non‐small cell lung cancer (NSCLC)? A pooled analysis of 6494 patients in 12 studies, examining survival and magnitude of benefit. Journal of Clinical Oncology2005;23(16S):7140. ">Bria 2005</a>; <a href="./references#CD011430-bbs2-0069" title="HamadaC , TanakaF , OhtaM , FujimuraS , KodamaK , ImaizumiM , et al. Meta‐analysis of postoperative adjuvant chemotherapy with tegafur‐uracil in non‐small cell lung cancer. Journal of Clinical Oncology2005;23(22):4999‐5006. ">Hamada 2005</a>; <a href="./references#CD011430-bbs2-0071" title="HottaK , MatsuoK , UeokaH , KiuraK , TabataM , TanimotoM . Role of adjuvant chemotherapy in patients with resected non‐small cell lung cancer: Reappraisal with a meta‐analysis of randomised controlled trials. Journal of Clinical Oncology2004;22(19):3860‐7. ">Hotta 2004</a>; <a href="./references#CD011430-bbs2-0078" title="PignonJP , TribodetH , ScagliottiGV , DouillardJY , ShepherdFA , StephensRJ , et al. Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE Collaborative Group. Journal of Clinical Oncology 2008;26(21):3552‐9. ">Pignon 2008</a>; <a href="./references#CD011430-bbs2-0084" title="SedrakyanA , van DerMeulenJ , O'ByrneK , PrendivilleJ , HillJ , TreasureT . Postoperative chemotherapy for non‐small cell lung cancer: A systematic review and meta‐analysis. Journal of Thoracic and Cardiovascular Surgery2004;128(3):414‐9. ">Sedrakyan 2004</a>) showing significant survival benefits with adjuvant chemotherapy, that is chemotherapy given after surgery, have included a variety of trials and patients (<a href="#CD011430-tbl-0001">Table 1</a>). </p> <div class="table" id="CD011430-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Recent meta‐analyses of surgery (+/‐ radiotherapy) + chemotherapy versus surgery (+/‐ radiotherapy)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Author</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type of data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of trials</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of patients</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Hazard Ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0071" title="HottaK , MatsuoK , UeokaH , KiuraK , TabataM , TanimotoM . Role of adjuvant chemotherapy in patients with resected non‐small cell lung cancer: Reappraisal with a meta‐analysis of randomised controlled trials. Journal of Clinical Oncology2004;22(19):3860‐7. ">Hotta 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5716</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.81 to 0.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0084" title="SedrakyanA , van DerMeulenJ , O'ByrneK , PrendivilleJ , HillJ , TreasureT . Postoperative chemotherapy for non‐small cell lung cancer: A systematic review and meta‐analysis. Journal of Thoracic and Cardiovascular Surgery2004;128(3):414‐9. ">Sedrakyan 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.81 to 0.93)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0064" title="BerghmansT , PaesmansM , MeertAP , MascauxC , LothaireP , LafitteJJ , et al. Survival improvement in resectable non‐small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta‐analysis of the literature. Lung Cancer2005;49(1):13‐23. ">Berghmans 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7644</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (0.79 to 0.91)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0065" title="BriaE , GrallaRJ , RaftopoulousH , FerrettiG , FeliciA , NisticoC . Does adjuvant chemotherapy improve survival in non‐small cell lung cancer (NSCLC)? A pooled analysis of 6494 patients in 12 studies, examining survival and magnitude of benefit. Journal of Clinical Oncology2005;23(16S):7140. ">Bria 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 + 1 meta‐analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6494</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (0.89 to 0.95)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0069" title="HamadaC , TanakaF , OhtaM , FujimuraS , KodamaK , ImaizumiM , et al. Meta‐analysis of postoperative adjuvant chemotherapy with tegafur‐uracil in non‐small cell lung cancer. Journal of Clinical Oncology2005;23(22):4999‐5006. ">Hamada 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual participant data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6**</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74 (0.61 to 0.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0078" title="PignonJP , TribodetH , ScagliottiGV , DouillardJY , ShepherdFA , StephensRJ , et al. Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE Collaborative Group. Journal of Clinical Oncology 2008;26(21):3552‐9. ">Pignon 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual participant data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5†</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4584</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> <p>Event‐free survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.82 to 0.96)</p> <p>0.84 (0.78 to 0.91)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>* Recent trials only</p> <p>**UFT trials only</p> <p>† Large (&gt; 300 patients) and recent cisplatin trials only</p> </div> </div> </section> <section id="CD011430-sec-0038"> <h3 class="title" id="CD011430-sec-0038">Description of the intervention</h3> <p>This review concentrated on randomised controlled trials that had tested surgery alone with drug treatment (chemotherapy) with or with out radiotherapy after surgery. These trials mainly used cisplatin‐based chemotherapy, this is commonly used for treatment of lung cancer as well as other cancers. Some trials, mainly those that took place in Asia, used UFT (also called tegafur/uracil) chemotherapy. </p> </section> <section id="CD011430-sec-0039"> <h3 class="title" id="CD011430-sec-0039">How the intervention might work</h3> <p>If the tumour is early stage, for example, not too big and has not spread to other parts of the body, doctors usually operate to remove it. At the same time, they will also remove a bit of the lung, or the entire lung that has the tumour. They may also give radiotherapy after the operation, aiming to kill any remaining cancer cells. They may also give chemotherapy after surgery to lower the risk of the cancer coming back. This treatment is called adjuvant chemotherapy. </p> </section> <section id="CD011430-sec-0040"> <h3 class="title" id="CD011430-sec-0040">Why it is important to do this review</h3> <p>The aim of this review was to assess more reliably the effects of adjuvant chemotherapy, with or without postoperative radiotherapy, in two new comprehensive IPD meta‐analyses. Contrary to our previous meta‐analyses, the present study is restricted to patients with early stage disease. </p> <p>Results of these two meta‐analyses were first published in The Lancet in 2010 (<a href="./references#CD011430-bbs2-0087" title="Non‐Small Cell Lung Cancer Collaborative Group. Adjuvant chemotherapy, with or without postopertative radiotherapy, in operable non‐small cell lung cancer: two meta‐analyses of individual patient data. Lancet2010;375(9722):1267‐77. ">NSCLC Meta‐analysis Collaborative Group 2010</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011430-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011430-sec-0041">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011430-sec-0107">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011430-sec-0041"></div> <p>To compare, in terms of overall survival, time to locoregional recurrence, time to distant recurrence and recurrence‐free survival: </p> <p>A. Surgery versus surgery plus adjuvant chemotherapy<br/> B. Surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy </p> <p>in patients with histologically diagnosed early stage non‐small cell lung cancer.</p> <p>(2)To investigate whether or not predefined patient subgroups benefit more or less from cisplatin‐based chemotherapy in terms of survival. </p> <p>Part A was carried out by the MRC CTU at UCL in London, UK and Part B was carried out by the Institute Gustave Roussy, Villejuif, France. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011430-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011430-sec-0042">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011430-sec-0108">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011430-sec-0042"></div> <section id="CD011430-sec-0043"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011430-sec-0044"> <h4 class="title">Types of studies</h4> <p>To be included, both published and unpublished completed trials had to be properly randomised using established methods (not quasi‐randomised). Trials could not have been confounded by additional therapeutic differences between the two arms and must have commenced randomisation on or after 1 January 1965. Trials should have aimed to include patients who had undergone a potentially curative resection and not received previous chemotherapy. For the first meta‐analysis, trials should have compared surgery versus surgery plus adjuvant chemotherapy. For the second, trials should have compared surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy. We excluded trials using long‐term alkylating agents for more than a year because these are no longer used to treat non‐small cell lung cancer (NSCLC), and have been shown to be harmful (<a href="./references#CD011430-bbs2-0075" title="Non‐Small Cell Lung Cancer Collaborative Group. Chemotherapy in non‐small cell lung cancer: a meta‐analysis using updated data on individual patients from 52 randomised clinical trials. BMJ1995;311(7010):899‐909. ">NSCLC Collaborative Group 1995</a>). </p> </section> <section id="CD011430-sec-0045"> <h4 class="title">Types of participants</h4> <p>Eligible trials included individuals with histologically confirmed NSCLC who had undergone a potentially curative resection. We included individual participant data from all randomised patients in the meta‐analyses, and where possible obtained data for individuals who had been excluded from the original trial analyses. We excluded from the meta‐analyses patients with small cell lung cancer that were included in early trials that randomised all types of lung cancer. </p> </section> <section id="CD011430-sec-0046"> <h4 class="title">Types of interventions</h4> <p>We classified trials as belonging to one of the following categories of chemotherapy.</p> <p> <ul id="CD011430-list-0001"> <li> <p>Surgery versus surgery plus adjuvant chemotherapy</p> <ul id="CD011430-list-0002"> <li> <p>platinum plus vinca alkaloid/etoposide</p> </li> <li> <p>platinum plus vinorelbine</p> </li> <li> <p>platinum plus taxane</p> </li> <li> <p>other platinum regimens</p> </li> <li> <p>platinum plus vinca alkaloid plus tegafur and uracil/tegafur</p> </li> <li> <p>tegafur and uracil/tegafur plus other agent</p> </li> <li> <p>tegafur and uracil/tegafur</p> </li> </ul> </li> </ul> <ul id="CD011430-list-0003"> <li> <p>Surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy</p> <ul id="CD011430-list-0004"> <li> <p>platinum plus vinca alkaloid/etoposide</p> </li> <li> <p>platinum plus vinorelbine</p> </li> <li> <p>other platinum regimens</p> </li> <li> <p>antimetabolic agent only</p> </li> </ul> </li> </ul> </p> </section> <section id="CD011430-sec-0047"> <h4 class="title">Types of outcome measures</h4> <p>.</p> <section id="CD011430-sec-0048"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome was overall survival, defined as the time from randomisation until death by any cause. Living patients were censored on the date of last follow‐up </p> </section> <section id="CD011430-sec-0049"> <h5 class="title">Secondary outcomes</h5> <p>Recurrence‐free survival was defined as the time from randomisation until first recurrence, or death by any cause. Patients alive without disease were censored on the date of last follow‐up. To avoid bias from under‐reporting of subsequent events, time to locoregional recurrence was defined as the time from randomisation until first locoregional recurrence, with patients experiencing earlier distant recurrences being censored at the time of distant recurrence. Similarly, for time to distant recurrence, patients experiencing earlier locoregional recurrences were censored on that date. Patients who died without recurrence were censored on date of death. Data on quality of life and adverse events were not routinely collected in the trials and therefore could not be analysed in this review. </p> </section> </section> </section> <section id="CD011430-sec-0050"> <h3 class="title">Search methods for identification of studies</h3> <p>To limit publication bias, we included published and unpublished trials with no restriction based on language. We carried out searches of MEDLINE and CANCERLIT from 1995 (using The Cochrane Collaboration's optimal strategy (<a href="./references#CD011430-bbs2-0073" title="LefebvreC , ClarkeMJ . Identifying randomised trials. In: EggerM , SmithGD , AltmanDG editor(s). Systematic reviews in healthcare. 2nd Edition. London: BMJ Publishing Group, 2001:69‐87. ">Lefebvre 2001</a>; <a href="./references#CD011430-bbs2-0074" title="LefebvreC , ManheimerE , GlanvilleJ , Cochrane Information Retrieval Methods Group. Searching for studies. In: Higgins JPT, Green S, Editors. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008:95‐150. ">Lefebvre 2008</a>).We supplemented trial registers by handsearches of conference proceedings and reference lists of trial publications and review articles. We asked our collaborators if they knew of additional trials. We carried out initial searches in 2003 and regularly updated these; we carried out the most recent searches in December 2013. </p> <section id="CD011430-sec-0051"> <h4 class="title">Electronic searches</h4> <p>We modified The Cochrane Collaboration's optimum search strategy for retrieving randomised controlled trials (RCTs) from MEDLINE (<a href="./appendices#CD011430-sec-0090">Appendix 1</a>) to specifically retrieve RCTs of chemotherapy for NSCLC and used this search strategy to search MEDLINE and CANCERLIT (1995 to 2013). </p> <p>In addition, we searched the following electronic bibliographic databases.</p> <p> <ul id="CD011430-list-0005"> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) (1995 to 2013)</p> </li> <li> <p>Proceedings of American Society for Clinical Oncology (ASCO) (1995 to 2013)</p> </li> </ul> </p> <p>We used the following trial registers to supplement searches of electronic databases with trials that were not (yet) published or were still recruiting patients. </p> <p> <ul id="CD011430-list-0006"> <li> <p>United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Trials Register</p> </li> <li> <p>ClinicalTrials.gov</p> </li> <li> <p>Physicians Data Query Protocols (open and closed)</p> </li> <li> <p>Current Controlled Trials ‘metaRegister’ of controlled trials</p> </li> </ul> </p> </section> <section id="CD011430-sec-0052"> <h4 class="title">Searching other resources</h4> <section id="CD011430-sec-0053"> <h5 class="title">Handsearches</h5> <p>We carried out the following handsearches to identify trials that may have only been reported as abstracts or that might have been missed in the searches described above. </p> <p> <ul id="CD011430-list-0007"> <li> <p>Proceedings of the American Society for Clinical Oncology (ASCO) 1993 to 1994</p> </li> <li> <p>Proceedings of the International Association for the Study of Lung Cancer (IASLC) World Lung Cancer Conference 1997 to 2013 </p> </li> <li> <p>Proceedings of the European Society of Medical Oncology (ESMO) 1996 to 2013</p> </li> <li> <p>Proceedings of the European Cancer Conference Organization (ECCO) 1995 to 2013</p> </li> </ul> </p> </section> <section id="CD011430-sec-0054"> <h5 class="title">Reference lists</h5> <p>We searched bibliographies of all identified trials and review articles.</p> </section> <section id="CD011430-sec-0055"> <h5 class="title">Correspondence</h5> <p>We asked all participating trialists to review and supplement a provisional list of trials. </p> </section> </section> </section> <section id="CD011430-sec-0056"> <h3 class="title" id="CD011430-sec-0056">Data collection and analysis</h3> <section id="CD011430-sec-0057"> <h4 class="title">Selection of studies</h4> <p>Four Members of the Project Management Group (SB, AA, JPP, LA) checked all titles and abstracts, identified by both electronic searching and handsearching of conference proceedings, and obtained the full publications for those thought to be potentially relevant. We sought individual participant data (IPD) from trial authors, including updated follow‐up, where available. </p> </section> <section id="CD011430-sec-0058"> <h4 class="title">Data extraction and management</h4> <p>We sought individual participant data for all eligible trials. For the 15 trials originally included in the 1995 analysis of the NSCLC Collaborative Group, we only sought updated follow‐up. For new trials, we sought data on age, sex, extent of resection, pathological tumour stage, histology, performance status, treatment arm, date of randomisation, recurrence, survival and follow‐up for all patients randomised. </p> <p>We used standard checks to identify missing data. We verified the data, for example, by checking the order of the dates, and assessed data validity and consistency. To assess randomisation integrity, we checked patterns of treatment allocation and balance of baseline characteristics by treatment arm. We checked follow‐up of surviving patients to ensure that it was balanced by treatment arm and up‐to‐date. We resolved any queries and each trial investigator or statistician verified the final database. </p> <section id="CD011430-sec-0059"> <h5 class="title">Project co‐ordination</h5> <p>Two teams co‐ordinated the project management. Each team collected and checked data and analysed results for their comparison as follows: </p> <p> <ul id="CD011430-list-0008"> <li> <p>Team A: surgery versus surgery plus adjuvant chemotherapy (MRC CTU at UCL, London, UK); </p> </li> <li> <p>Team B: surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy (Institut Gustave Roussy, Villejuif, France). </p> </li> </ul> </p> </section> </section> <section id="CD011430-sec-0060"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the included studies using The Cochrane Collaboration's 'Risk of bias' tool outlined in Table 8.5c of the Cochrane Handbook for Systematic Reviews of Interventions (<a href="./references#CD011430-bbs2-0070" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Handbook for Systematic Reviews of Interventions ‐ Version 5.0.1 (updated in September 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) and these studies were checked by a second review author. We considered adequate sequence generation and allocation concealment to be most important and therefore a judgement of low risk was desirable for these domains for all trials. Blinding was not appropriate due to the nature of the treatments and any issues surrounding the reporting of incomplete outcome data, selective outcome reporting or attrition bias were overcome by the collection of IPD. </p> </section> <section id="CD011430-sec-0061"> <h4 class="title">Measures of treatment effect</h4> <p>Unless otherwise stated, we prespecified all analyses in the protocols, and carried out on an intention‐to‐treat analysis. For each outcome, we used the logrank expected number of events and variance to calculate individual trial hazard ratios (HRs), which were pooled across trials using the fixed‐effect model. We presented overall survival using simple (non‐stratified) Kaplan‐Meier curves. We computed the median follow‐up for all patients using the reverse Kaplan‐Meier method (<a href="./references#CD011430-bbs2-0083" title="SchemperM , SmithTL . A note on quantifying follow‐up in studies of failure time. Controlled Clinical Trials1996;17(4):343‐6. ">Schemper 1996</a>). </p> <p>To explore any impact of trial characteristics on the effect of adjuvant chemotherapy on overall survival, we calculated pooled HRs for each prespecified trial group and used Chi<sup>2</sup> tests for interaction to investigate differences in the treatment effect across these trial groups. </p> <p>We calculated absolute differences in overall survival at five years using overall HRs and control group survival. If we identified a difference in effect by trial group or patient subgroup, we used HRs and control group survival for the relevant groups to calculate absolute differences; otherwise we used the overall HR. </p> <p>As two trials compared two adjuvant chemotherapy regimens with one control arm, we compared each treatment arm with the control arm and analysed these as separate trial comparisons in different chemotherapy categories (<a href="./references#CD011430-bbs2-0022" title="TeramatsuT , Society of adjuvant chemotherapy for lung cancer surgery in West Japan. Assessment of postoperative adjuvant chemotherapy on non‐small cell lung cancer (abstract). Lung Cancer1991;7(Suppl):124. WadaH , HitomiS , TakashiT , West Japan Study Group for Lung Cancer Surgery. Adjuvant chemotherapy after complete resection in non‐small cell lung cancer (full publication). Journal of Clinical Oncology1996;14:1048‐54. ">A22 WJSG 2 (1+3)</a>; <a href="./references#CD011430-bbs2-0025" title="ImaizumiM . Postoperative adjuvant cisplatin, vindesine, plus uracil‐tegafur chemotherapy increased survival of patients with completely resected p‐stage I non‐small cell lung cancer. Lung Cancer2005;49:85‐94. ">A25 ACTLC4a</a>; <a href="./references#CD011430-bbs2-0029" title="WadaH , HitomiS , TakashiT , : West Japan Study Group for Lung Cancer Surgery. Adjuvant chemotherapy after complete resection in non‐small cell lung cancer. Journal of Clinical Oncology1996;14:1048‐54. ">A29 WJSG2 (2+3)</a>; <a href="./references#CD011430-bbs2-0033" title="ImaizumiM . Postoperative adjuvant cisplatin, vindesine, plus uracil‐tegafur chemotherapy increased survival of patients with completely resected p‐stage I non‐small cell lung cancer. Lung Cancer2005;49:85‐94. ">A33 ACTLC4b</a>). To avoid double‐counting the control arms in the overall and subgroup analyses, however, we combined the treatment arms and compared them with the relevant control arm. Because of this, there are no overall totals in <a href="#CD011430-fig-0001">Figure 1</a>. For other trials that belonged in different chemotherapy categories (<a href="./references#CD011430-bbs2-0006" title="ScagliottiGV , FossatiR , TorriV , CrinòL , GiacconeG , SilvanoG , et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II or IIIa non‐small cell lung cancer. Journal of the National Cancer Institute2003;95(19):1453‐61. ">A06 ALPI1</a>; <a href="./references#CD011430-bbs2-0040" title="ScagliottiGV , FossatiR , TorriV , CrinòL , GiacconeG , SilvanoG , et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II or IIIa non‐small cell lung cancer. Journal of the National Cancer Institute2003;95(19):1453‐61. ">B06 ALPI2</a>), different meta‐analyses or both (<a href="./references#CD011430-bbs2-0007" title="ArriagadaR , DunantA , PignonJ‐P , BergmanB , ChabowskiM , GrunenwaldD , et al. Long‐term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin‐based chemotherapy in resected lung cancer. Journal of Clinical Oncology2010;28:35‐42. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin‐based adjuvant chemotherapy in patients with completely resected non‐small cell lung cancer. New England Journal of Medicine2004;350:351‐60. ">A07 IALT1</a>; <a href="./references#CD011430-bbs2-0008" title="WallerD , PeakeMD , StephensRJ , GowerNH , MilroyR , ParmarMKB , et al. Chemotherapy for patients with non‐small cell lung cancer: the surgical setting of the Big Lung Trial. European Journal of Cardio‐Thoracic Surgery2004;26:173‐82. ">A08 BLT1</a>; <a href="./references#CD011430-bbs2-0012" title="ArriagadaR , DunantA , PignonJ‐P , BergmanB , ChabowskiM , GrunenwaldD , et al. Long‐term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin‐based chemotherapy in resected lung cancer. Journal of Clinical Oncology2010;28:35‐42. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin‐based adjuvant chemotherapy in patients with completely resected non‐small cell lung cancer. New England Journal of Medicine2004;350:351‐60. ">A12 IALT2</a>; <a href="./references#CD011430-bbs2-0013" title="WallerD , PeakeMD , StephensRJ , GowerNH , MilroyR , ParmarMKB , et al. Chemotherapy for patients with non‐small cell lung cancer: the surgical setting of the Big Lung Trial. European Journal of Cardio‐Thoracic Surgery2004;26:173‐82. ">A13 BLT2</a>; <a href="./references#CD011430-bbs2-0018" title="WallerD , PeakeMD , StephensRJ , GowerNH , MilroyR , ParmarMKB , et al. Chemotherapy for patients with non‐small cell lung cancer: the surgical setting of the Big Lung Trial. European Journal of Cardio‐Thoracic Surgery2004;26:173‐82. ">A18 BLT3</a>; <a href="./references#CD011430-bbs2-0020" title="SawamuraK , MoriT , DoiO , YasumitsuT , KawaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">A20 OLCSG1c</a>; <a href="./references#CD011430-bbs2-0027" title="SawamuraK , MoriT , DoiO , YasumitsuT , KuwaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">A27 OLCSG1b</a>; <a href="./references#CD011430-bbs2-0028" title="SawamuraK , MoriT , DoiO , YasumitsuT , KuwaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">A28 OLCSG1a</a>; <a href="./references#CD011430-bbs2-0041" title="ArriagadaR , DunantA , PignonJ‐P , BergmanB , ChabowskiM , GrunenwaldD , et al. Long‐term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin‐based chemotherapy in resected lung cancer. Journal of Clinical Oncology2010;28:35‐42. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin‐based adjuvant chemotherapy in patients with completely resected non‐small cell lung cancer. New England Journal of Medicine2004;350:351‐60. ">B07 IALT3</a>; <a href="./references#CD011430-bbs2-0042" title="WallerD , PeakeMD , StephensRJ , GowerNH , MilroyR , ParmarMKB , et al. Chemotherapy for patients with non‐small cell lung cancer: the surgical setting of the Big Lung Trial. European Journal of Cardio‐Thoracic Surgery2004;26:173‐82. ">B08 BLT4</a>; <a href="./references#CD011430-bbs2-0044" title="ArriagadaR , DunantA , PignonJ‐P , BergmanB , ChabowskiM , GrunenwaldD , et al. Long‐term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin‐based chemotherapy in resected lung cancer. Journal of Clinical Oncology2010;28:35‐42. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin‐based adjuvant chemotherapy in patients with completely resected non‐small cell lung cancer. New England Journal of Medicine2004;350:351‐60. ">B10 IALT4</a>; <a href="./references#CD011430-bbs2-0047" title="SawamuraK , MoriT , DoiO , YasumitsuT , KawaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">B13 OLCSG1d</a>) we compared relevant patients from the treatment arm with the corresponding control arm patients, and analysed them as separate trial comparisons. This gives a greater number of trial comparisons than there are trials. </p> <div class="figure" id="CD011430-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="For all chemotherapy groups, HR 0.86 (0.81 to 92); p&lt; 0.0001 Forest plot of comparison: 1 surgery versus surgery + chemotherapy, outcome: 1.1 survival." data-id="CD011430-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>For all chemotherapy groups, HR 0.86 (0.81 to 92); p&lt; 0.0001</b> </p> <p>Forest plot of comparison: 1 surgery versus surgery + chemotherapy, outcome: 1.1 survival.</p> </div> </div> </div> </section> <section id="CD011430-sec-0062"> <h4 class="title">Dealing with missing data</h4> <p>We outlined all desired variables in a protocol (available on request from SB). We requested any missing variables from those who carried out the trial. </p> </section> <section id="CD011430-sec-0063"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used Chi<sup>2</sup> tests and the I<sup>2</sup> statistic to test for differences in the treatment effect across groups of trials or groups of patients. </p> </section> <section id="CD011430-sec-0064"> <h4 class="title">Assessment of reporting biases</h4> <p>As we collected IPD, we did not encounter any reporting biases.</p> </section> <section id="CD011430-sec-0065"> <h4 class="title">Data synthesis</h4> <p>Where we could get data, we included all eligible trials in the analyses. The analyses were carried out in RevMan (<a href="./references#CD011430-bbs2-0082" title="The Cochrane Collaboration. Review Manager (RevMan). Computer Program. Version 5.3.5 Copenhagen: the Nordic Cochrane Centre. The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD011430-sec-0066"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>To investigate differences in the treatment effect across patient subgroups, we undertook Cox regressions, including the relevant treatment by subgroup interaction term within trials and the interaction coefficients (HRs) pooled across trials (<a href="./references#CD011430-bbs2-0068" title="FisherDJ , CopasAJ , TierneyJF , ParmarMKB . A critical review of methods for the assessment of patient‐level interactions in individual patient data (IPD) meta‐analysis of randomised trials, and guidance for practitioners. Journal of Clinical Epidemiology2011;64(9):949‐967. ">Fisher 2011</a>). We investigated whether there were differences in the treatment effect depending upon the patients' age, sex, histological cell type, tumour stage, or performance status. </p> </section> <section id="CD011430-sec-0067"> <h4 class="title">Sensitivity analysis</h4> <p>We outlined in the protocol that HRs for overall survival would be calculated, excluding any trials that were clear outliers. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011430-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011430-sec-0068"></div> <section id="CD011430-sec-0069"> <h3 class="title">Description of studies</h3> <section id="CD011430-sec-0070"> <h4 class="title">Surgery versus surgery plus adjuvant chemotherapy</h4> <p>We identified 35 eligible trials. We included 26 trials; nine from the 1995 meta‐analysis and 17 additional ones (see <a href="./references#CD011430-sec-0098" title="">Characteristics of included studies</a>). We could not include nine trials because data were not available for three published (<a href="./references#CD011430-bbs2-0048" title="AyoubJ , VigneaultE , HanleyJ , DuranceauA , RobidouxA , PagéA , et al. The Montreal multicenter trial in operable non‐small cell lung cancer (NSCLC): A multivariate analysis of the predictors of relapse. Proceedings of the American Society of Clinical Oncology1991;10:247. ">Ayoub 1991</a>; <a href="./references#CD011430-bbs2-0049" title="ClericiM , BarniS , CantaluppiG , et al. Adjuvant chemotherapy in non‐small cell lung cancer: a randomised trial. European Journal of Cancer1991;27(Suppl 2):S173. ">Clerici 1991</a>; <a href="./references#CD011430-bbs2-0051" title="IchinoseY , HaraN , OhtaM , MotohiroA , KudaT , AsoH . Postoperative adjuvant chemotherapy in non‐small cell lung cancer: Prognostic value of DNA ploidy and postrecurrent survival. Journal of Surgical Oncology1991;46:15‐20. ">Ichinose 1991</a>) and two unpublished trials (EORTC 08922; NCCTG 852451) (see <a href="./references#CD011430-sec-0099" title="">Characteristics of excluded studies</a>); adequate contact with the investigators could not be established for two trials (<a href="./references#CD011430-bbs2-0054" title="UedaH , SakadaT , KuwaharaM , MotohiroA . A small randomized phase III single‐center trial on postoperative UFT administration in patients with completely resected non‐small cell lung cancer. Anti‐Cancer Drugs2004;15(1):29‐33. ">Ueda 2004</a>; <a href="./references#CD011430-bbs2-0058" title="ZarogoulidisK , FilippouK , AntonioC , PapagiannisA , HatziapostolouP , TsiaggaP , et al. The impact of adjuvant chemotherapy on the survival of postoperative stage IIIa NSCLC patients. Proceedings of the 2nd International Congress on Lung Cancer. Crete. 1996:PO35. ">Zarogoulidis 1996</a>) and two other trials had only recently been presented (<a href="./references#CD011430-bbs2-0055" title="WangS , OuW , SunH , YangHX , FangQ . Adjuvant chemotherapy in completely resected stage III‐N2 non‐small cell lung cancer. Proceedings of the American Society of Clinical Oncology2009;27:A7563. ">Wang 2009</a>; <a href="./references#CD011430-bbs2-0057" title="WuY , YangX , ChenG , ZhongW , BenX‐S , GuL , et al. Adjuvant docetaxel plus carboplatin compared with surgery only in patients with completely resected stage IB‐IIIA non‐small cell lung cancer: final results of CSLC201/TAX210 with Chinese Society of Lung Cancer. Journal of Thoracic Oncology2009;4(9):S583‐S584. ">Wu 2009</a>). Therefore, we included data from 26 published trials, allowing 34 trial comparisons (<a href="./references#CD011430-bbs2-0001" title="KimuraH , YamaguchiY , FujisawaT , BabaM , ShibaM . A randomized controlled study of postoperative adjuvant chemoimmunotherapy of resected non‐small cell lung cancer with IL2 and LAK cells. Lung Cancer1991;7(Suppl):113. ">A01 IPCR, Chiba</a>; <a href="./references#CD011430-bbs2-0002" title="OhtaM , TsuchiyaR , ShimoyamaM , SawamuraK , MoriT , MiyazawaN , et al. Adjuvant chemotherapy for completely resected stage III non‐small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery1993;106:703‐8. ">A02 JLCSSG</a>; <a href="./references#CD011430-bbs2-0003" title="MineoTC , AmbrogiV , CorsaroV , RoselliM . Postoperative adjuvant therapy for stage IB non‐small cell lung cancer. European Journal of Cardio‐Thoracic Surgery2001;20(2):378‐84. ">A03 Mineo</a>; <a href="./references#CD011430-bbs2-0004" title="ParkJH , LeeC‐T , LeeHW , BaekHJ , ZoJI , ShimYM . Postoperative adjuvant chemotherapy for stage I non‐small cell lung cancer. European Journal of Cardio‐Thoracic Surgery2005;27:1086‐91. ">A04 Park1</a>; <a href="./references#CD011430-bbs2-0005" title="ParkJH . Postoperative adjuvant therapy for stage IIIA non‐small cell lung cancer. Journal of Thoracic Oncology2007;2(8 Suppl 4):S651. ">A05 Park2</a>; <a href="./references#CD011430-bbs2-0006" title="ScagliottiGV , FossatiR , TorriV , CrinòL , GiacconeG , SilvanoG , et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II or IIIa non‐small cell lung cancer. Journal of the National Cancer Institute2003;95(19):1453‐61. ">A06 ALPI1</a>; <a href="./references#CD011430-bbs2-0007" title="ArriagadaR , DunantA , PignonJ‐P , BergmanB , ChabowskiM , GrunenwaldD , et al. Long‐term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin‐based chemotherapy in resected lung cancer. Journal of Clinical Oncology2010;28:35‐42. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin‐based adjuvant chemotherapy in patients with completely resected non‐small cell lung cancer. New England Journal of Medicine2004;350:351‐60. ">A07 IALT1</a>; <a href="./references#CD011430-bbs2-0008" title="WallerD , PeakeMD , StephensRJ , GowerNH , MilroyR , ParmarMKB , et al. Chemotherapy for patients with non‐small cell lung cancer: the surgical setting of the Big Lung Trial. European Journal of Cardio‐Thoracic Surgery2004;26:173‐82. ">A08 BLT1</a>; <a href="./references#CD011430-bbs2-0009" title="TadaH , TsuchiyaR , IchinoseY , KoikeT , NishizawaN , NagaiK , et al. A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non‐small cell lung cancer (JCOG 9304). Lung Cancer2004;43:167‐73. ">A09 JCOG 9304</a>; <a href="./references#CD011430-bbs2-0010" title="DouillardJY , RosellR , DeLenaM , CarpagnanoF , RamlauR , Gonzales‐LarribaJL , et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB‐IIIA non‐small‐cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncology2006;7:719‐27. ">A10 ANITA1</a>; <a href="./references#CD011430-bbs2-0011" title="ButtsCA , DingK , SeymourL , Twumasi‐AnkrahP , GrahamB , GandaraD , et al. Randomised phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage Ib and II non‐small cell lung cancer: Updated survival analysis of JBR‐10. Journal of Clinical Oncology2010;28:29‐34. WintonT , LivingstonR , JohnsonD , RigasJ , JohnstonM , ButtsC , et al. Vinorelbine plus cisplatin vs observation in resected non‐small cell lung cancer. New England Journal of Medicine2005;352:2589‐97. ">A11 JBR10</a>; <a href="./references#CD011430-bbs2-0012" title="ArriagadaR , DunantA , PignonJ‐P , BergmanB , ChabowskiM , GrunenwaldD , et al. Long‐term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin‐based chemotherapy in resected lung cancer. Journal of Clinical Oncology2010;28:35‐42. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin‐based adjuvant chemotherapy in patients with completely resected non‐small cell lung cancer. New England Journal of Medicine2004;350:351‐60. ">A12 IALT2</a>; <a href="./references#CD011430-bbs2-0013" title="WallerD , PeakeMD , StephensRJ , GowerNH , MilroyR , ParmarMKB , et al. Chemotherapy for patients with non‐small cell lung cancer: the surgical setting of the Big Lung Trial. European Journal of Cardio‐Thoracic Surgery2004;26:173‐82. ">A13 BLT2</a>; <a href="./references#CD011430-bbs2-0014" title="StraussGM , HerndonJE2nd , MaddausMA , JohnstoneDW , JohnsonEA , HarpoleDH , et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non‐small‐cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. Journal of Clinical Oncology2008;26(31):5043‐51. ">A14 CALGB 9633</a>; <a href="./references#CD011430-bbs2-0015" title="FeldR , RubinsteinL , ThomasPA . Adjuvant chemotherapy with cyclophosphamide, doxorubicin and cisplatin in patients with completely resected stage I non‐small‐cell lung cancer. Journal of the National Cancer Institute1993;85(4):299‐306. ">A15 LCSG 801</a>; <a href="./references#CD011430-bbs2-0016" title="NiiranenA , Niitamo‐KorhonenS , KouriM , AssendelftA , MattsonK , PyrhönenS . Adjuvant chemotherapy after radical surgery for non‐small cell lung cancer: A randomized study. Journal of Clinical Oncology1992;10(12):1927‐32. ">A16 FLCSG 1</a>; <a href="./references#CD011430-bbs2-0017" title="FiglinRA , PiantodosiS . A phase 3 randomized trial of immediate combination chemotherapy vs delayed combination chemotherapy in patients with completely resected stage II and III non‐small cell carcinoma of the lung. Chest1994;106(Suppl 6):310S‐2S. ">A17 LCSG 853</a>; <a href="./references#CD011430-bbs2-0018" title="WallerD , PeakeMD , StephensRJ , GowerNH , MilroyR , ParmarMKB , et al. Chemotherapy for patients with non‐small cell lung cancer: the surgical setting of the Big Lung Trial. European Journal of Cardio‐Thoracic Surgery2004;26:173‐82. ">A18 BLT3</a>; <a href="./references#CD011430-bbs2-0019" title="Study Group for Adjuvant Chemotherapy for Lung Cancer. A randomised controlled trial of postoperative adjuvant chemotherapy in non‐small cell lung cancer (in Japanese). Hai‐gan1992;32:481‐6. ">A19 SGACLC ACTLC1</a>; <a href="./references#CD011430-bbs2-0020" title="SawamuraK , MoriT , DoiO , YasumitsuT , KawaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">A20 OLCSG1c</a>; <a href="./references#CD011430-bbs2-0021" title="Study Group for Adjuvant Chemotherapy for Lung Cancer. A randomized trial of postoperative adjuvant chemotherapy in non‐small cell lung cancer (the second cooperative study). European Journal of Surgical Oncology1995;21(1):69‐77. ">A21 SGACLC ACTLC2</a>; <a href="./references#CD011430-bbs2-0022" title="TeramatsuT , Society of adjuvant chemotherapy for lung cancer surgery in West Japan. Assessment of postoperative adjuvant chemotherapy on non‐small cell lung cancer (abstract). Lung Cancer1991;7(Suppl):124. WadaH , HitomiS , TakashiT , West Japan Study Group for Lung Cancer Surgery. Adjuvant chemotherapy after complete resection in non‐small cell lung cancer (full publication). Journal of Clinical Oncology1996;14:1048‐54. ">A22 WJSG 2 (1+3)</a>; <a href="./references#CD011430-bbs2-0023" title="WadaH , MiyaharaR , TanakaF , HitomiS , West Japan Study Group for Lung Cancer Surgery. Post‐operative adjuvant chemotherapy with PVM (cisplatin + vindesine + mitomycin c) and UFT (uracil and tegaful) in resected stage I‐II NSCLC (non‐small cell lung cancer): a randomised clinical trial. European Journal of Cardio‐Thoracic Surgery 1999;15:438‐43. ">A23 WJSG3</a>; <a href="./references#CD011430-bbs2-0024" title="XuG , RongT , LinP . Adjuvant chemotherapy following radical surgery for non‐small cell lung cancer: a randomized study. Zhonghua Zhong Liu Za Zhi1998;20(3):228‐30. ">A24 Xu</a>; <a href="./references#CD011430-bbs2-0025" title="ImaizumiM . Postoperative adjuvant cisplatin, vindesine, plus uracil‐tegafur chemotherapy increased survival of patients with completely resected p‐stage I non‐small cell lung cancer. Lung Cancer2005;49:85‐94. ">A25 ACTLC4a</a>; <a href="./references#CD011430-bbs2-0026" title="NakagawaK , TadaH , AkashiA , YasumitsuT , IuchiK , TakiT , et al. Randomised study of adjuvant chemotherapy for completely resected p stage I‐IIIa non‐small cell lung cancer. British Journal of Cancer2006;95:817‐21. ">A26 OLCSG2b</a>; <a href="./references#CD011430-bbs2-0027" title="SawamuraK , MoriT , DoiO , YasumitsuT , KuwaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">A27 OLCSG1b</a>; <a href="./references#CD011430-bbs2-0028" title="SawamuraK , MoriT , DoiO , YasumitsuT , KuwaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">A28 OLCSG1a</a>; <a href="./references#CD011430-bbs2-0029" title="WadaH , HitomiS , TakashiT , : West Japan Study Group for Lung Cancer Surgery. Adjuvant chemotherapy after complete resection in non‐small cell lung cancer. Journal of Clinical Oncology1996;14:1048‐54. ">A29 WJSG2 (2+3)</a>; <a href="./references#CD011430-bbs2-0030" title="NakagawaM , TanakaF , TsubotaN , OhtaM , TakaoM , WadaH . A randomised phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non‐small cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG) ‐ the 4th study. Annals of Oncology2005;16:75‐80. ">A30 WJSG4</a>; <a href="./references#CD011430-bbs2-0031" title="EndoC , SaitoiY , IwanawiH , TsushimaT , ImaiT , KawamuraM , et al. A randomized trial of postoperative UFT in p stage I, II non‐small cell lung cancer: North‐East Japan Study Group for Lung Cancer Surgery. Lung Cancer2003;40:181‐6. ">A31 NJSGLCS</a>; <a href="./references#CD011430-bbs2-0032" title="NakagawaK , TadaH , AkashiA , YasumitsuT , IuchiK , TakiT , et al. Randomised study of adjuvant chemotherapy for completely resected p stage I‐IIIa non‐small cell lung cancer. British Journal of Cancer2006;95:817‐21. ">A32 OLCSG2a</a>; <a href="./references#CD011430-bbs2-0033" title="ImaizumiM . Postoperative adjuvant cisplatin, vindesine, plus uracil‐tegafur chemotherapy increased survival of patients with completely resected p‐stage I non‐small cell lung cancer. Lung Cancer2005;49:85‐94. ">A33 ACTLC4b</a>; <a href="./references#CD011430-bbs2-0034" title="KatoH , IchinoseY , OhtaM , HataE , TsubotaN , TadaH , et al. A randomised trial of adjuvant chemotherapy with uracil‐tegafur for adenocarcinoma of the lung. New England Journal of Medicine2004;350(17):1713‐21. ">A34 JLCRG</a>). </p> <p>Platinum‐based chemotherapy, without tegafur plus uracil or tegafur alone was used in 18 trial comparisons (<a href="./references#CD011430-bbs2-0001" title="KimuraH , YamaguchiY , FujisawaT , BabaM , ShibaM . A randomized controlled study of postoperative adjuvant chemoimmunotherapy of resected non‐small cell lung cancer with IL2 and LAK cells. Lung Cancer1991;7(Suppl):113. ">A01 IPCR, Chiba</a>; A02 JLCSSG; A03 Mineo; A04 Park1; A05 Park2; A06 ALPI1; A07 IALT1; A08 BLT1; A09 JCOG 9304; A10 ANITA1; A11 JBR10; A12 IALT2; A13 BLT2; A14 CALGB 9633; A15 LCSG 801; A16 FLCSG 1; A17 LCSG 853; A18 BLT3) and platinum‐based chemotherapy with tegafur or with tegafur plus uracil was used in eight (<a href="./references#CD011430-bbs2-0019" title="Study Group for Adjuvant Chemotherapy for Lung Cancer. A randomised controlled trial of postoperative adjuvant chemotherapy in non‐small cell lung cancer (in Japanese). Hai‐gan1992;32:481‐6. ">A19 SGACLC ACTLC1</a>; A20 OLCSG1c; A21 SGACLC ACTLC2; A22 WJSG 2 (1+3); A23 WJSG3; A24 Xu; A25 ACTLC4a; A26 OLCSG2b). In all but one (<a href="./references#CD011430-bbs2-0014" title="StraussGM , HerndonJE2nd , MaddausMA , JohnstoneDW , JohnsonEA , HarpoleDH , et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non‐small‐cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. Journal of Clinical Oncology2008;26(31):5043‐51. ">A14 CALGB 9633</a>), cisplatin was the platinum agent. Tegafur or tegafor plus uracil were used in combination with other agents in one trial comparison (<a href="./references#CD011430-bbs2-0027" title="SawamuraK , MoriT , DoiO , YasumitsuT , KuwaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">A27 OLCSG1b</a>) and alone in seven (<a href="./references#CD011430-bbs2-0028" title="SawamuraK , MoriT , DoiO , YasumitsuT , KuwaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">A28 OLCSG1a</a>; A29 WJSG2 (2+3); A30 WJSG4; A31 NJSGLCS; A32 OLCSG2a; A33 ACTLC4b; A34 JLCRG). Data on histology and stage were provided for all 34 trial comparisons, age and sex for 33, and performance status for 24 (<a href="#CD011430-tbl-0002">Table 2</a>). Patients were mostly men with a median age of 61 years (range 18 to 84). They tended to have good performance status and tumours that were predominantly stage I‐II adenocarcinomas or squamous cell carcinomas. Staging methods would have changed over time but the methods used were the same in both treatment arms in the trials. We combined the small number of patients with stage IIIB and IV tumours (included for example, because of misclassification at diagnosis (<a href="#CD011430-tbl-0002">Table 2</a>), with stage IIIA patients for analysis; this group is subsequently referred to as stage III. The median follow‐up was 5.5 years. </p> <div class="table" id="CD011430-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Patient characteristics for trials of surgery + chemotherapy versus surgery and for trials of surgery + radiotherapy + chemotherapy versus surgery + radiotherapy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Characteristic</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgery + CT*</b> </p> <p><b>(n = 4305)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgery</b> </p> <p><b>(n = 4142)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgery + RT** + CT</b> </p> <p><b>(n = 1315)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgery + RT</b> </p> <p><b>(n = 1345)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age (years)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1827 (46%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1669 (44%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>692 (53%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>693 (51%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 ‐ 64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>898 (17%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>900 (18%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>270 (20%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>292 (22%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65 ‐ 69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>872 (20%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>878 (21%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>253 (19%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>253 (19%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt;= 70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>593 (14%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>583 (14%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 (8%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107 (8%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>115 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>112 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sex</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Male</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2948 (68%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2876 (69%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1023 (78%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1062 (79%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Female</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1238 (29%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1149 (28%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>291 (22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>281 (21%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>117 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (&lt; 1%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adenocarcinoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2257 (52%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2158(52%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>499 (38%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>501 (37%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Squamous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1649 (38%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1587 (38%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>642 (49%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>655 (49%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>386 (9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>391 (9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>172 (13%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>184 (14%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 (&lt; 1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Stage</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2851 (66%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2772 (67%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14 (1%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>806 (19%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>793 (19%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>450 (34%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>473 (35%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IIIa</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>586 (14%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>512 (12%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>804 (61%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>801 (60%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IIIb</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42 (1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 (2%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stage III Unspecified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3(&lt;1%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 (0%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17 (1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 (2%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Performance status</b>† </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Good</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3172 (74%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3022 (73%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>948 (72%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>969 (72%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81 (6%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105 (8%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58 (1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 (1%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not supplied</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>961 (22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>979 (24%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>264 (20%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>255 (19%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Extent of resection</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Complete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4119 (96%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3951 (95%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1097 (83%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1121 (83%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>123 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179 (14%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>186 (14%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66 (1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38 (3%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiotherapy timing</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CT before RT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>941 (72%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>963 (72%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Concomitant CT + RT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>374 (28%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>382 (28%)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*CT = Chemotherapy</p> <p>**RT = Radiotherapy</p> <p>†Good = 0,1 ECOG/WHO or 100 ‐ 70 Karnofsky; Poor &gt; 2 ECOG/OMS or &lt;= 60 Karnofsky</p> </div> </div> </section> <section id="CD011430-sec-0071"> <h4 class="title">Surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy</h4> <p>We identified 15 eligible trials. We included 12 trials; six from the 1995 meta‐analysis and six additional ones (see <a href="./references#CD011430-sec-0098" title="">Characteristics of included studies</a>) . We could not include three for the following reasons: data were not available for one trial (<a href="./references#CD011430-bbs2-0048" title="AyoubJ , VigneaultE , HanleyJ , DuranceauA , RobidouxA , PagéA , et al. The Montreal multicenter trial in operable non‐small cell lung cancer (NSCLC): A multivariate analysis of the predictors of relapse. Proceedings of the American Society of Clinical Oncology1991;10:247. ">Ayoub 1991</a>), and adequate contact with investigators could not be made for two trials (<a href="./references#CD011430-bbs2-0052" title="KimS‐W , SuhCS , LeeG‐W , RyuM‐H , LeeSD , KimWS , et al. The number of tumor (+) N2 nodes as a prognostic factor in the patients with N2 disease non‐small cell lung cancer after curative resection and postoperative thoracic radiotherapy. Lung Cancer2003;41(Supplement 2):S152. ">Kim 2003</a>; <a href="./references#CD011430-bbs2-0056" title="WolfM , MüllerH , SeifartU , FriedelG , HruskaD , SerkeM , et al. Randomized phase III trial of adjuvant radiotherapy versus adjuvant chemotherapy followed by radiotherapy in patients with N2 positive non‐small cell lung cancer (NSCLC). Proceedings of the American Society of Clinical Oncology2001;20:311a. ">Wolf 2001</a>) (see <a href="./references#CD011430-sec-0099" title="">Characteristics of excluded studies</a>). Therefore, we included nine published and three unpublished trials, allowing 13 trial comparisons (<a href="./references#CD011430-bbs2-0035" title="PistersKMW , KrisMG , GrallaRT , HilarisB , McCormackPM , BainsMS . Randomized trial comparing post‐operative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non‐small cell lung cancer. Journal of Surgical Oncology1994;56:236‐241. ">B01 MSKCC 80‐53</a>; <a href="./references#CD011430-bbs2-0036" title="DautzenbergB , ChastangC , ArriagadaR , LeChevalierT , BelpommeD , HurdebourcqM , et al. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected non‐small cell lung cancer. Cancer1995;76:779‐86. ">B02 GETCB 01CB82</a>; <a href="./references#CD011430-bbs2-0037" title="EORTC Lung Cancer Cooperative Group. Phase III randomized trial of adjuvant radiotherapy vs radiotherapy plus chemotherapy with DDP/VDS vs no adjuvant therapy in patients with completely resected non‐small cell lung cancer. ">B03 EORTC 08861</a>; <a href="./references#CD011430-bbs2-0038" title="MD Anderson Cancer Centre. Phase III randomized comparison of chest irradiation vs combination chemotherapy with cyclophosphamide/etoposide/cisplatine (CEP) followed by chest irradiation in patients with partially resected stage II/III limited non small cell lung cancer. ">B04 MDA DM 87045</a>; <a href="./references#CD011430-bbs2-0039" title="KellerSM , AdakS , WagnerH , HerskovicA , KomakiR , BrookesBJ , et al. Postoperative adjuvant therapy in patients with stage II or IIIa non‐small cell lung cancer. New England Journal of Medicine2000;343:1217‐22. ">B05 INT 0115</a>; <a href="./references#CD011430-bbs2-0040" title="ScagliottiGV , FossatiR , TorriV , CrinòL , GiacconeG , SilvanoG , et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II or IIIa non‐small cell lung cancer. Journal of the National Cancer Institute2003;95(19):1453‐61. ">B06 ALPI2</a>; <a href="./references#CD011430-bbs2-0041" title="ArriagadaR , DunantA , PignonJ‐P , BergmanB , ChabowskiM , GrunenwaldD , et al. Long‐term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin‐based chemotherapy in resected lung cancer. Journal of Clinical Oncology2010;28:35‐42. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin‐based adjuvant chemotherapy in patients with completely resected non‐small cell lung cancer. New England Journal of Medicine2004;350:351‐60. ">B07 IALT3</a>; <a href="./references#CD011430-bbs2-0042" title="WallerD , PeakeMD , StephensRJ , GowerNH , MilroyR , ParmarMKB , et al. Chemotherapy for patients with non‐small cell lung cancer: the surgical setting of the Big Lung Trial. European Journal of Cardio‐Thoracic Surgery2004;26:173‐82. ">B08 BLT4</a>; <a href="./references#CD011430-bbs2-0043" title="DouillardJY , RosellR , DeLenaM , CarpagnanoF , RamlauR , Gonzales‐LarribaJL , et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB‐IIIA non‐small‐cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncology2006;7:719‐27. ">B09 ANITA2</a>; <a href="./references#CD011430-bbs2-0044" title="ArriagadaR , DunantA , PignonJ‐P , BergmanB , ChabowskiM , GrunenwaldD , et al. Long‐term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin‐based chemotherapy in resected lung cancer. Journal of Clinical Oncology2010;28:35‐42. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin‐based adjuvant chemotherapy in patients with completely resected non‐small cell lung cancer. New England Journal of Medicine2004;350:351‐60. ">B10 IALT4</a>; <a href="./references#CD011430-bbs2-0045" title="LadT . The comparison of CAP chemotherapy and radiotherapy to radiotherapy alone for resected lung cancer with positive margin or involved highest sampled paratracael node (stage IIIa). Chest1994;106(6):303S. LadT , RubinsteinL , SadeghiA . The benefit of adjuvant treatment for resected locally advanced non‐small cell lung cancer. Journal of Clinical Oncology1988;6:9‐17. ">B11 LCSG 791</a>; <a href="./references#CD011430-bbs2-0046" title="Niiranen , KouriM , PyrhonenS , MattsonK . Postsurgical radiotherapy versus postsurgical radiotherapy plus chemotherapy for non‐small cell lung cancer. ">B12 FLCSG 3</a>; <a href="./references#CD011430-bbs2-0047" title="SawamuraK , MoriT , DoiO , YasumitsuT , KawaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">B13 OLCSG1d</a>). </p> <p>In nine trial comparisons (<a href="./references#CD011430-bbs2-0036" title="DautzenbergB , ChastangC , ArriagadaR , LeChevalierT , BelpommeD , HurdebourcqM , et al. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected non‐small cell lung cancer. Cancer1995;76:779‐86. ">B02 GETCB 01CB82</a>; B04 MDA DM 87045; B06 ALPI2; B07 IALT3; B08 BLT4; B09 ANITA2; B10 IALT4; B12 FLCSG 3; B13 OLCSG1d), chemotherapy was given before radiotherapy, and in four it was given concurrently with radiotherapy (<a href="./references#CD011430-bbs2-0035" title="PistersKMW , KrisMG , GrallaRT , HilarisB , McCormackPM , BainsMS . Randomized trial comparing post‐operative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non‐small cell lung cancer. Journal of Surgical Oncology1994;56:236‐241. ">B01 MSKCC 80‐53</a>; B03 EORTC 08861; B05 INT 0115; B11 LCSG 791) . Platinum and a vinca alkaloid or etoposide were used in 10 trial comparisons (<a href="./references#CD011430-bbs2-0035" title="PistersKMW , KrisMG , GrallaRT , HilarisB , McCormackPM , BainsMS . Randomized trial comparing post‐operative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non‐small cell lung cancer. Journal of Surgical Oncology1994;56:236‐241. ">B01 MSKCC 80‐53</a>; B02 GETCB 01CB82; B03 EORTC 08861; B04 MDA DM 87045; B05 INT 0115; B06 ALPI2; B07 IALT3; B08 BLT4; B09 ANITA2; B10 IALT4), platinum and tegafur plus uracil/tegafur in one (<a href="./references#CD011430-bbs2-0047" title="SawamuraK , MoriT , DoiO , YasumitsuT , KawaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">B13 OLCSG1d</a>), and other platinum regimens in two trials (<a href="./references#CD011430-bbs2-0045" title="LadT . The comparison of CAP chemotherapy and radiotherapy to radiotherapy alone for resected lung cancer with positive margin or involved highest sampled paratracael node (stage IIIa). Chest1994;106(6):303S. LadT , RubinsteinL , SadeghiA . The benefit of adjuvant treatment for resected locally advanced non‐small cell lung cancer. Journal of Clinical Oncology1988;6:9‐17. ">B11 LCSG 791</a>; B12 FLCSG 3). Cisplatin was the sole platinum agent. Data on age, sex and histology were supplied for all trial comparisons, stage and extent of resection for 12, and performance status for 11. Based on these data, patients were mostly men, with good performance status, a median age of 59 years (range 27 to 81), and stage III, squamous carcinomas. We combined the few patients with stage IV tumours with stage III patients for analyses, and referred to this group as stage III. The median follow‐up was 6.4 years. </p> </section> </section> <section id="CD011430-sec-0072"> <h3 class="title">Risk of bias in included studies</h3> <p>We only included trials with adequate methods of randomisation. We excluded trials using quasi‐random methods, such as birth date. We thoroughly checked all raw data received on individual patients to ensure both the accuracy of the meta‐analysis database and the quality of randomisation and follow‐up. We resolved any queries and verified the final database entries by discussion with the responsible trial investigator or statistician. No RCTs were blinded due to the nature of the intervention, but the primary outcome is not likely to be influenced by the lack of blinding. We received IPD for all outcomes of interest, therefore we considered reporting bias to be low for all RCTs. We considered all included trials to be at a low risk of bias (see <a href="#CD011430-fig-0002">Figure 2</a> and <a href="#CD011430-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD011430-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD011430-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011430-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD011430-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> </section> <section id="CD011430-sec-0073"> <h3 class="title" id="CD011430-sec-0073">Effects of interventions</h3> <section id="CD011430-sec-0074"> <h4 class="title">Surgery versus surgery plus adjuvant chemotherapy</h4> <p>Overall survival results for the first meta‐analysis were based on 34 trial comparisons and 8447 patients (3323 deaths), representing 92% of patients who were randomly assigned. The results (<a href="./references#CD011430-fig-0010" title="">Analysis 1.1</a>) show a benefit of adjuvant chemotherapy (hazard ratio (HR) 0.86, 95% confidence interval (CI) 0.81 to 0.92, p&lt; 0.0001; <a href="#CD011430-fig-0001">Figure 1</a>), with minimum heterogeneity (p=0.40, I² = 4%). This finding represents an absolute improvement of 4% (95% CI 3 to 6) at five years, increasing overall survival from 60% to 64% (<a href="#CD011430-fig-0004">Figure 4</a>). We noted a difference in effect by chemotherapy category (interaction p= 0.06, <a href="#CD011430-fig-0001">Figure 1</a>), largely driven by the result of the trial comparison,<a href="./references#CD011430-bbs2-0027" title="SawamuraK , MoriT , DoiO , YasumitsuT , KuwaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">A27 OLCSG1b</a>, that alone constituted the chemotherapy category for tegafur plus uracil or tegafur plus another agent. A sensitivity analysis excluding this trial did not suggest that this drug regimen affects the effect of adjuvant chemotherapy (data not shown; interaction p= 0.30). </p> <div class="figure" id="CD011430-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Simple (non‐stratified Kaplan‐Meier curves for trials of Surgery (S) and chemotherapy (CT) versus surgery alone and for trials of surgery and chemotherapy and radiotherapy (RT) versus surgery and radiotherapy." data-id="CD011430-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Simple (non‐stratified Kaplan‐Meier curves for trials of Surgery (S) and chemotherapy (CT) versus surgery alone and for trials of surgery and chemotherapy and radiotherapy (RT) versus surgery and radiotherapy. </p> </div> </div> </div> <p>In view of the differences in the types of chemotherapy used over time and by geographical region, we grouped trial comparisons by these characteristics for exploratory analyses. We noted no clear evidence of a difference in the effect between trial comparisons included in the 1995 meta‐analysis, and those included since this time (interaction p= 0.76), by accrual decade (interaction p= 0.61), or by geographical region (North America, Europe, Asia; interaction p= 0.25; data not shown). Trial comparisons using tegafur plus uracil or tegafur alone all originated in Asia, and recruited more women (n = 1293 of 3465 (37%)), and more patients with stage I tumours (3003/3673 (82%)) of adenocarcinoma histology (2505/3673 (68%)) than those that did not use tegafur plus uracil or tegafur alone (1093/4745 (23%)), (2613/4724 (55%)), (1910/4744 (40%)), respectively. However, we recorded no clear evidence of a difference in treatment effect between trial comparisons that did (3848 (45%); HR 0.80, 95% CI 0.71 to 0.90) and those that did not (4751 (55%); HR 0.89, 95% CI 0.82 to 0.97) use tegafur plus uracil or tegafur alone (overall HR 0.86, 95% CI 0.81 to 0.92, interaction p = 0.16; <a href="#CD011430-fig-0005">Figure 5</a>), even when we excluded the trial comparison <a href="./references#CD011430-bbs2-0027" title="SawamuraK , MoriT , DoiO , YasumitsuT , KuwaharaO , KuwabaraM , et al. A prospective randomized controlled study of the postoperative adjuvant therapy for non‐small cell lung cancer. Lung Cancer1988;4:A166. ">A27 OLCSG1b</a> (data not shown; interaction p = 0.07). </p> <div class="figure" id="CD011430-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Exploratory analyses of the effect of surgery (S) and chemotherapy (CT) versus surgery on survival, by the use of tegafur plus uracil/tegafur." data-id="CD011430-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Exploratory analyses of the effect of surgery (S) and chemotherapy (CT) versus surgery on survival, by the use of tegafur plus uracil/tegafur. </p> </div> </div> </div> <p>We recorded no significant evidence (p ≥ 0.10) that any patient subgroup defined by age, sex, histology, performance status, or stage benefited more or less from adjuvant chemotherapy (<a href="#CD011430-fig-0006">Figure 6</a>). However, because of the geographical differences in the types of patients and chemotherapy used, we undertook exploratory subgroup analyses separately for trial comparisons using platinum, without tegafur plus uracil or tegafur alone, and those using these drugs. We split stage I disease into IA and IB for all but five trial comparisons (<a href="./references#CD011430-bbs2-0004" title="ParkJH , LeeC‐T , LeeHW , BaekHJ , ZoJI , ShimYM . Postoperative adjuvant chemotherapy for stage I non‐small cell lung cancer. European Journal of Cardio‐Thoracic Surgery2005;27:1086‐91. ">A04 Park1</a>; <a href="./references#CD011430-bbs2-0019" title="Study Group for Adjuvant Chemotherapy for Lung Cancer. A randomised controlled trial of postoperative adjuvant chemotherapy in non‐small cell lung cancer (in Japanese). Hai‐gan1992;32:481‐6. ">A19 SGACLC ACTLC1</a>; <a href="./references#CD011430-bbs2-0021" title="Study Group for Adjuvant Chemotherapy for Lung Cancer. A randomized trial of postoperative adjuvant chemotherapy in non‐small cell lung cancer (the second cooperative study). European Journal of Surgical Oncology1995;21(1):69‐77. ">A21 SGACLC ACTLC2</a>; <a href="./references#CD011430-bbs2-0026" title="NakagawaK , TadaH , AkashiA , YasumitsuT , IuchiK , TakiT , et al. Randomised study of adjuvant chemotherapy for completely resected p stage I‐IIIa non‐small cell lung cancer. British Journal of Cancer2006;95:817‐21. ">A26 OLCSG2b</a>; <a href="./references#CD011430-bbs2-0032" title="NakagawaK , TadaH , AkashiA , YasumitsuT , IuchiK , TakiT , et al. Randomised study of adjuvant chemotherapy for completely resected p stage I‐IIIa non‐small cell lung cancer. British Journal of Cancer2006;95:817‐21. ">A32 OLCSG2a</a>) which we had to exclude since this information was not available. </p> <div class="figure" id="CD011430-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="The effect of surgery (S) and chemotherapy (CT) versus surgery on survival by patient subgroup." data-id="CD011430-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>The effect of surgery (S) and chemotherapy (CT) versus surgery on survival by patient subgroup. </p> </div> </div> </div> <p>For the platinum without tegafur plus uracil or tegafur alone group, although there was no evidence of difference in the effect of adjuvant chemotherapy between patients with good and poor performance status (interaction p = 0.30; <a href="#CD011430-fig-0007">Figure 7</a>), we noted an increasing relative effect of adjuvant chemotherapy with improving performance status (trend p = 0.002; <a href="#CD011430-fig-0007">Figure 7</a>), which was consistent across trials (data not shown; p = 0.32). However, a few patients had a poor performance status (<a href="#CD011430-fig-0007">Figure 7</a>). The relative effect of adjuvant chemotherapy did not differ significantly by other patient subgroups, including stage (trend p = 0.13; <a href="#CD011430-fig-0007">Figure 7</a>). Therefore, application of the overall hazard ratio to survival in the control group by stage suggests absolute improvements in 5‐year survival of 3% (95% CI 2 to 5) for stage IA (from 70% to 73%), 5% (2 to 7) for stage IB (from 55% to 60%), 5% (3 to 8) for stage II (from 40% to 45%), and 5% (3 to 8) for stage III disease (from 30% to 35%). The suggested survival benefit of 3% for stage IA and the hazard ratio of 1.19 (95% CI 0.84 to 1.68) for that subgroup seemed to be contradictory. However, data are scarce for this group of patients, the CIs are very wide, and the result is not significant (p = 0.33). </p> <div class="figure" id="CD011430-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Exploratory analyses of the effect of surgery (S) and chemotherapy (CT) versus surgery on survival, by use of tegafur plus uracil or tegafur and by stage and performance status." data-id="CD011430-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Exploratory analyses of the effect of surgery (S) and chemotherapy (CT) versus surgery on survival, by use of tegafur plus uracil or tegafur and by stage and performance status. </p> </div> </div> </div> <p>In the tegafur and uracil or tegafur alone group, we noted no clear difference in the effect of adjuvant chemotherapy between patients with good or poor performance status (interaction p = 0.49; <a href="#CD011430-fig-0007">Figure 7</a>), but did record a suggestion of an increasing relative effect of adjuvant chemotherapy with worsening performance status (trend p = 0.02; <a href="#CD011430-fig-0007">Figure 7</a>). This trend varies substantially across trials (data not shown; p = 0.01), and few patients had a poor performance status. We noted no significant difference in the relative effect of adjuvant chemotherapy by age, sex, histology, or stage, and application of the overall HR gave absolute improvements in 5‐year survival of 2% (95% CI 1 to 3) for stage IA (from 80% to 82%), 3% (1 to 4) for stage IB (from 75% to 78%), 5% (2 to 7) for stage II (from 45% to 50%), and 5% (3 to 8) for stage III disease (from 25% to 30%). </p> <p>Data for recurrence‐free survival were available for 18 trial comparisons (2519 events; 5379 patients) and data for locoregional (936 events; 5226 patients) and distant recurrence (1267 events; 5224 patients) for 16 trial comparisons, mostly from newer trials of platinum‐based chemotherapy without tegafur plus uracil or tegafur alone. Results for recurrence‐free survival (HR 0.83, 95% CI 0.77 to 0.90, p &lt; 0.0001), time to locoregional recurrence (HR 0.75, 95% CI 0.66 to 0.85, p &lt; 0.0001), and time to distant recurrence (HR 0.80, 95% CI 0.72 to 0.89, p = 0.0007) all significantly favoured adjuvant chemotherapy. Exclusion of the four trial comparisons that included tegafur plus uracil or tegafur alone (<a href="./references#CD011430-bbs2-0023" title="WadaH , MiyaharaR , TanakaF , HitomiS , West Japan Study Group for Lung Cancer Surgery. Post‐operative adjuvant chemotherapy with PVM (cisplatin + vindesine + mitomycin c) and UFT (uracil and tegaful) in resected stage I‐II NSCLC (non‐small cell lung cancer): a randomised clinical trial. European Journal of Cardio‐Thoracic Surgery 1999;15:438‐43. ">A23 WJSG3</a>; <a href="./references#CD011430-bbs2-0024" title="XuG , RongT , LinP . Adjuvant chemotherapy following radical surgery for non‐small cell lung cancer: a randomized study. Zhonghua Zhong Liu Za Zhi1998;20(3):228‐30. ">A24 Xu</a>; <a href="./references#CD011430-bbs2-0033" title="ImaizumiM . Postoperative adjuvant cisplatin, vindesine, plus uracil‐tegafur chemotherapy increased survival of patients with completely resected p‐stage I non‐small cell lung cancer. Lung Cancer2005;49:85‐94. ">A33 ACTLC4b</a>; <a href="./references#CD011430-bbs2-0034" title="KatoH , IchinoseY , OhtaM , HataE , TsubotaN , TadaH , et al. A randomised trial of adjuvant chemotherapy with uracil‐tegafur for adenocarcinoma of the lung. New England Journal of Medicine2004;350(17):1713‐21. ">A34 JLCRG</a>) showed similar results (data not shown). </p> </section> <section id="CD011430-sec-0075"> <h4 class="title">Surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy</h4> <p>Overall survival analyses were based on 12 trial comparisons and 2660 patients (1909 deaths), representing 86% of patients who were randomly assigned. The results (<a href="./references#CD011430-fig-0011" title="">Analysis 2.1</a>) showed a clear benefit of adjuvant chemotherapy (HR 0.88, 95% CI 0.81 to 0.97, p = 0.009; <a href="#CD011430-fig-0008">Figure 8</a>), with little heterogeneity (p = 0.95, I² = 0%). This finding represents an absolute benefit of 4% (95% CI 1 to 8) at 5 years, increasing survival from 29% to 33% (<a href="#CD011430-fig-0004">Figure 4</a>). We recorded no evidence of a differential effect by chemotherapy category (interaction p = 0.45; <a href="#CD011430-fig-0008">Figure 8</a>) or the extent of resection achieved: trials with complete resection only (6 trials, 2005 patients; HR 0.87, 95% CI 0.78 to 0.97) versus trials with complete or incomplete resection (6 trials, 655 patients; HR 0.92, 95% CI 0.78 to 1.08); interaction p = 0.63. Furthermore, an exploratory analysis suggests that the timing of chemotherapy in relation to radiotherapy is unimportant: trials with chemotherapy before radiotherapy (9 trials, 1928 patients; HR 0.86, 95% CI 0.77 to 0.96) versus trials with concomitant chemoradiotherapy (3 trials, 732 patients; HR 0.95, 95% CI 0.81 to 1.12); interaction p = 0.30. </p> <div class="figure" id="CD011430-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 surgery + radiotherapy versus surgery + radiotherapy + chemotherapy, outcome: 2.1 Survival." data-id="CD011430-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 surgery + radiotherapy versus surgery + radiotherapy + chemotherapy, outcome: 2.1 Survival. </p> </div> </div> </div> <p>The relative effect of adjuvant chemotherapy did not differ significantly by age, sex, histology, performance status, or stage (<a href="#CD011430-fig-0009">Figure 9</a>). Data for recurrence‐free survival, and locoregional and distant recurrence were available for eight trial comparisons (2247 patients). Results for recurrence‐free survival (1673 events, 2247 patients; HR 0.85, 95% CI 0.77 to 0.93, p = 0.0006), time to locoregional recurrence (533 events; HR 0.79, 95% CI 0.67 to 0.94, p = 0.008), and time to distant recurrence (806 events; HR 0.75, 95% CI 0.66 to 0.87, p &lt; 0.0001) all showed a significant benefit of adjuvant chemotherapy. </p> <div class="figure" id="CD011430-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="The effect of surgery (S) and radiotherapy (RT) and chemotherapy (CT) versus surgery and radiotherapy on survival by patient subgroup." data-id="CD011430-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>The effect of surgery (S) and radiotherapy (RT) and chemotherapy (CT) versus surgery and radiotherapy on survival by patient subgroup. </p> </div> </div> </div> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011430-sec-0076" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011430-sec-0076">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011430-sec-0116">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011430-sec-0076"></div> <section id="CD011430-sec-0077"> <h3 class="title" id="CD011430-sec-0077">Summary of main results</h3> <p>Our results show a benefit of adjuvant chemotherapy after surgery, which has been already shown in some large trials but not in others (for example, <a href="./references#CD011430-bbs2-0006" title="ScagliottiGV , FossatiR , TorriV , CrinòL , GiacconeG , SilvanoG , et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II or IIIa non‐small cell lung cancer. Journal of the National Cancer Institute2003;95(19):1453‐61. ">A06 ALPI1</a> and <a href="./references#CD011430-bbs2-0014" title="StraussGM , HerndonJE2nd , MaddausMA , JohnstoneDW , JohnsonEA , HarpoleDH , et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non‐small‐cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. Journal of Clinical Oncology2008;26(31):5043‐51. ">A14 CALGB 9633</a>). They also show a benefit of chemotherapy in the presence of postoperative radiotherapy. The absolute survival improvements of 4% at five years are fairly modest, but might result in 10,000 to 16,000 more patients alive at five years (<a href="./references#CD011430-bbs2-0067" title="DattaD , LahiriB . Preoperative evaluation of patients undergoing lung resection surgery. Chest2003;123(6):2096‐103. ">Datta 2003</a>). The results of the two meta‐analyses are based on data from 47 comparisons in 33 trials and 11,107 patients with non‐small cell lung cancer (NSCLC), which is more than three times that available in the <a href="./references#CD011430-bbs2-0075" title="Non‐Small Cell Lung Cancer Collaborative Group. Chemotherapy in non‐small cell lung cancer: a meta‐analysis using updated data on individual patients from 52 randomised clinical trials. BMJ1995;311(7010):899‐909. ">NSCLC Collaborative Group 1995</a>. In these meta‐analyses, we have an opportunity to bring together most trials undertaken during the past few decades, and to assess the effectiveness of adjuvant chemotherapy in patients with NSCLC worldwide. </p> <p>Although we noted no significant difference in effect between chemotherapy categories in the first meta‐analysis, results for the trials that used older vinca alkaloids (vinblastine, vindesine, vincristine), etoposide, or other platinum combinations were somewhat uncertain, whereas trials using a combination of platinum and vinorelbine provided slightly more reliable evidence of benefit to inform present clinical practice (<a href="#CD011430-fig-0001">Figure 1</a>; <a href="#CD011430-fig-0008">Figure 8</a>). The results for chemotherapy with tegafur plus uracil or tegafur alone are similar to those for platinum‐based regimens. However, results come largely from older studies in Asian populations, which are increasingly showing differences in their response to treatment (<a href="./references#CD011430-bbs2-0085" title="SekineI , YamamotoN , NishoK , SaijoN . Emerging ethnic differences in lung cancer therapy. British Journal of Cancer2008;99(11):1757‐62. ">Sekine 2008</a>), and so cannot be extrapolated to modern practice in non‐Asian patients. A trial of tegafur plus uracil or tegafur alone in patients with stage IA, adenocarcinoma from non‐Asian countries would be beneficial in this context. Results of an ongoing trial might establish the relative merits of carboplatin‐paclitaxel and tegafur plus uracil in Asian patients (<a href="./references#CD011430-bbs2-0086" title="ToyookaS , HottaK , NakamuraH , NakataM , TadaH , YamashitaM , et al. A multicenter, phase III study of carboplatin/paclitaxel, versus oral uracil‐tegafur as the adjuvant chemotherapy in resected non‐small cell lung cancer (NSCLC): planned interim analyses. Proceedings of the American Society of Clinical Oncology2009;27(15):A7560. ">Toyooka 2009</a>). </p> <p>Guidelines from Cancer Care Ontario and American Society of Clinical Oncology (ASCO) (<a href="./references#CD011430-bbs2-0079" title="PistersKM , EvansWK , AzzoliCG , KrisMG , SmithCA , DeschCE , et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I‐IIIA resectable non small‐cell lung cancer guideline. Journal of Clinical Oncology2007;25(34):5506‐18. ">Pisters 2007</a>) recommend that adjuvant cisplatin‐based chemotherapy is given to patients with stage II and IIIA NSCLC. </p> <p>These guidelines state that evidence is insufficient to make recommendations for patients with stage IA disease, and one meta‐analysis (<a href="./references#CD011430-bbs2-0078" title="PignonJP , TribodetH , ScagliottiGV , DouillardJY , ShepherdFA , StephensRJ , et al. Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE Collaborative Group. Journal of Clinical Oncology 2008;26(21):3552‐9. ">Pignon 2008</a>) reported a significant decrease in the effect of adjuvant cisplatin‐based chemotherapy by stage, largely driven by the stage IA result. This meta‐analysis does not show significant differences in the effect of platinum chemotherapy (without tegafur plus uracil or tegafur alone) by stage or significantly poorer survival in patients with stage IA disease (<a href="#CD011430-fig-0007">Figure 7</a>). The evidence in stage IA tumours remains scarce until results from further trials are available. </p> <p>The ASCO guidelines also state that none of the studies reviewed showed a significant benefit of adjuvant chemotherapy in patients with stage IB tumours. By contrast, our estimate of the effect of platinum‐based adjuvant chemotherapy in patients with stage IB tumours is based on a substantial number of events and is similar to estimates for patients with stage II and III tumours (<a href="#CD011430-fig-0007">Figure 7</a>). Since we did not collect data for tumour size, patients with larger stage IB tumours, who would be classed as stage II in the 7th edition of the TNM staging system (<a href="./references#CD011430-bbs2-0072" title="International Association for the Study of Lung Cancer. Staging Manual in Thoracic Oncology. 1st Edition. Orange Park, FL, USA: Editorial Rx Press, 2009. ">IASLC 2009</a>) and might achieve a greater benefit from adjuvant chemotherapy are potentially included. In the absence of comorbidities and contraindications to chemotherapy, our findings show that adjuvant platinum‐based chemotherapy may be considered as a treatment option for patients at high risk of recurrence, ie, those with stage IB, II, or III disease. Whethercisplatin‐based chemotherapy should be used in patients with stage IA disease remains uncertain, since the scarcity of data did not allow us to distinguish reliably between a benefit, a detriment, or no effect. Most patients had good performance status and the benefit was clear in this group. A small increasing effect of platinum‐based chemotherapy with better performance status was also apparent in this and another meta‐analysis (<a href="./references#CD011430-bbs2-0078" title="PignonJP , TribodetH , ScagliottiGV , DouillardJY , ShepherdFA , StephensRJ , et al. Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE Collaborative Group. Journal of Clinical Oncology 2008;26(21):3552‐9. ">Pignon 2008</a>), but was not confirmed in trials using tegafur plus uracil or tegafur alone, or those that included postoperative radiotherapy. Nevertheless, these results could suggest cautious use of platinum‐based chemotherapy in less fit patients. Despite the amount of data collected, some of the subgroup analyses lacked power. </p> <p>The benefits of adjuvant chemotherapy have been reported to be attenuated in long‐term results (<a href="./references#CD011430-bbs2-0063" title="ArriagadaR , DunantA , PignonJ‐P , BergmanB , ChabowskiM , GrunenwaldD , et al. Long‐term results of the International Adjuvant Lung Cancer Trial evaluating adjuvant cisplatin‐based chemotherapy in resected lung cancer. Journal of Clinical Oncology2010;28(1):35‐42. ">Arriagada 2010</a>; <a href="./references#CD011430-bbs2-0066" title="ButtsCA , DingK , SeymourL , Twumasi‐AnkrahP , GrahamB , GandaraD , et al. Randomised phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage Ib and II non‐small cell lung cancer: Updated survival analysis of JBR‐10. Journal of Clinical Oncology2010;28(1):29‐34. ">Butts 2010</a>), however, we do not have much data beyond five years. The potential benefit of adjuvant chemotherapy should always be balanced with possible toxic effects for the individual patient. We were unable to assess toxic effects of treatment in this study. Moreover, extrapolation of the results to patients with comorbidities is uncertain because most of the patients included in these meta‐analyses had mild or no comorbidities. Quality of life was measured in only a few trials and so could not be reviewed. </p> </section> <section id="CD011430-sec-0078"> <h3 class="title" id="CD011430-sec-0078">Overall completeness and applicability of evidence</h3> <section id="CD011430-sec-0079"> <h4 class="title">Surgery versus surgery plus adjuvant chemotherapy</h4> <p>We identified 35 eligible trials and included 26. We could not include nine trials; five could not be included as data were not available; two could not be included as adequate contact could not be made with the trial investigators; and two were published too recently to be included (but will be included in a subsequent update). Therefore this represents 92% of all patients who were randomised into eligible trials. </p> </section> <section id="CD011430-sec-0080"> <h4 class="title">Surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy</h4> <p>We identified 15 eligible trials and included 12. We could not include three trials; one could not be included as data were not available; and two could not be included as adequate contact could not be made with the trial investigators. Therefore this represents 86% of all patients who were randomised into eligible trials. </p> </section> </section> <section id="CD011430-sec-0081"> <h3 class="title" id="CD011430-sec-0081">Quality of the evidence</h3> <p>The trials included in this update show an overall low risk of bias in the domains we considered to be most important; those being adequate sequence generation and allocation concealment. Blinding was not appropriate due to the nature of the treatments and any issues surrounding the reporting of incomplete outcome data, selective outcome reporting or attrition bias were overcome by the collection of individual participant data. We are confident that further research is unlikely to change the findings. The studies were well designed and conducted, address the review question and the effects are consistent across trials. The impact of any data we have not been able to include in our analyses is small. </p> </section> <section id="CD011430-sec-0082"> <h3 class="title" id="CD011430-sec-0082">Potential biases in the review process</h3> <p>We aimed to include all trials, unpublished and unpublished, regardless of the language they were published in. We collected IPD for all included trials. The first meta‐analysis (surgery versus surgery plus adjuvant chemotherapy) included 92% of eligible data and the second meta‐analysis (surgery plus radiotherapy versus surgery plus radiotherapy plus adjuvant chemotherapy) included 86% of eligible data. Had we been able to include this extra data, it is unlikely they would have had an impact on these results. We checked and verified data against the published results. We resolved any queries and verified the final database by each trial investigator or statistician. We deemed all included trials to have a low risk of bias using the 'Risk of bias' tool. </p> </section> <section id="CD011430-sec-0083"> <h3 class="title" id="CD011430-sec-0083">Agreements and disagreements with other studies or reviews</h3> <p>This is an update and extension of a previous systematic review and meta‐analysis. The results are still in favour of the addition of chemotherapy to surgery and postoperative radiotherapy, however these results are more up to date and contain more than three times more patients than that available in 1995. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011430-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/urn:x-wiley:14651858:media:CD011430:CD011430-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_t/tCD011430-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="For all chemotherapy groups, HR 0.86 (0.81 to 92); p&lt; 0.0001 Forest plot of comparison: 1 surgery versus surgery + chemotherapy, outcome: 1.1 survival." data-id="CD011430-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p><b>For all chemotherapy groups, HR 0.86 (0.81 to 92); p&lt; 0.0001</b> </p> <p>Forest plot of comparison: 1 surgery versus surgery + chemotherapy, outcome: 1.1 survival.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011430-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/urn:x-wiley:14651858:media:CD011430:CD011430-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_t/tCD011430-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD011430-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011430-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/urn:x-wiley:14651858:media:CD011430:CD011430-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_t/tCD011430-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD011430-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011430-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/urn:x-wiley:14651858:media:CD011430:CD011430-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_t/tCD011430-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Simple (non‐stratified Kaplan‐Meier curves for trials of Surgery (S) and chemotherapy (CT) versus surgery alone and for trials of surgery and chemotherapy and radiotherapy (RT) versus surgery and radiotherapy." data-id="CD011430-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Simple (non‐stratified Kaplan‐Meier curves for trials of Surgery (S) and chemotherapy (CT) versus surgery alone and for trials of surgery and chemotherapy and radiotherapy (RT) versus surgery and radiotherapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011430-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/urn:x-wiley:14651858:media:CD011430:CD011430-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_t/tCD011430-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Exploratory analyses of the effect of surgery (S) and chemotherapy (CT) versus surgery on survival, by the use of tegafur plus uracil/tegafur." data-id="CD011430-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Exploratory analyses of the effect of surgery (S) and chemotherapy (CT) versus surgery on survival, by the use of tegafur plus uracil/tegafur. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011430-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/urn:x-wiley:14651858:media:CD011430:CD011430-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_t/tCD011430-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="The effect of surgery (S) and chemotherapy (CT) versus surgery on survival by patient subgroup." data-id="CD011430-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>The effect of surgery (S) and chemotherapy (CT) versus surgery on survival by patient subgroup. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011430-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/urn:x-wiley:14651858:media:CD011430:CD011430-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_t/tCD011430-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Exploratory analyses of the effect of surgery (S) and chemotherapy (CT) versus surgery on survival, by use of tegafur plus uracil or tegafur and by stage and performance status." data-id="CD011430-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Exploratory analyses of the effect of surgery (S) and chemotherapy (CT) versus surgery on survival, by use of tegafur plus uracil or tegafur and by stage and performance status. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011430-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/urn:x-wiley:14651858:media:CD011430:CD011430-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_t/tCD011430-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 surgery + radiotherapy versus surgery + radiotherapy + chemotherapy, outcome: 2.1 Survival." data-id="CD011430-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 surgery + radiotherapy versus surgery + radiotherapy + chemotherapy, outcome: 2.1 Survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011430-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/urn:x-wiley:14651858:media:CD011430:CD011430-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_t/tCD011430-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="The effect of surgery (S) and radiotherapy (RT) and chemotherapy (CT) versus surgery and radiotherapy on survival by patient subgroup." data-id="CD011430-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>The effect of surgery (S) and radiotherapy (RT) and chemotherapy (CT) versus surgery and radiotherapy on survival by patient subgroup. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011430-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/urn:x-wiley:14651858:media:CD011430:CD011430-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_t/tCD011430-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Surgery versus surgery + adjuvant chemotherapy, Outcome 1 Survival." data-id="CD011430-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Surgery versus surgery + adjuvant chemotherapy, Outcome 1 Survival.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011430/references#CD011430-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011430-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/urn:x-wiley:14651858:media:CD011430:CD011430-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_t/tCD011430-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Surgery + radiotherapy versus surgery + radiotherapy + adjuvant chemotherapy, Outcome 1 Survival." data-id="CD011430-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Surgery + radiotherapy versus surgery + radiotherapy + adjuvant chemotherapy, Outcome 1 Survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011430/references#CD011430-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011430/media/CDSR/CD011430/image_n/nCD011430-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD011430-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Recent meta‐analyses of surgery (+/‐ radiotherapy) + chemotherapy versus surgery (+/‐ radiotherapy)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Author</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type of data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of trials</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of patients</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Hazard Ratio (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0071" title="HottaK , MatsuoK , UeokaH , KiuraK , TabataM , TanimotoM . Role of adjuvant chemotherapy in patients with resected non‐small cell lung cancer: Reappraisal with a meta‐analysis of randomised controlled trials. Journal of Clinical Oncology2004;22(19):3860‐7. ">Hotta 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5716</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.81 to 0.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0084" title="SedrakyanA , van DerMeulenJ , O'ByrneK , PrendivilleJ , HillJ , TreasureT . Postoperative chemotherapy for non‐small cell lung cancer: A systematic review and meta‐analysis. Journal of Thoracic and Cardiovascular Surgery2004;128(3):414‐9. ">Sedrakyan 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.81 to 0.93)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0064" title="BerghmansT , PaesmansM , MeertAP , MascauxC , LothaireP , LafitteJJ , et al. Survival improvement in resectable non‐small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta‐analysis of the literature. Lung Cancer2005;49(1):13‐23. ">Berghmans 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7644</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (0.79 to 0.91)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0065" title="BriaE , GrallaRJ , RaftopoulousH , FerrettiG , FeliciA , NisticoC . Does adjuvant chemotherapy improve survival in non‐small cell lung cancer (NSCLC)? A pooled analysis of 6494 patients in 12 studies, examining survival and magnitude of benefit. Journal of Clinical Oncology2005;23(16S):7140. ">Bria 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 + 1 meta‐analysis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6494</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (0.89 to 0.95)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0069" title="HamadaC , TanakaF , OhtaM , FujimuraS , KodamaK , ImaizumiM , et al. Meta‐analysis of postoperative adjuvant chemotherapy with tegafur‐uracil in non‐small cell lung cancer. Journal of Clinical Oncology2005;23(22):4999‐5006. ">Hamada 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual participant data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6**</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74 (0.61 to 0.88)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011430-bbs2-0078" title="PignonJP , TribodetH , ScagliottiGV , DouillardJY , ShepherdFA , StephensRJ , et al. Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE Collaborative Group. Journal of Clinical Oncology 2008;26(21):3552‐9. ">Pignon 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual participant data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5†</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4584</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Survival</p> <p>Event‐free survival</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.82 to 0.96)</p> <p>0.84 (0.78 to 0.91)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>* Recent trials only</p> <p>**UFT trials only</p> <p>† Large (&gt; 300 patients) and recent cisplatin trials only</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Recent meta‐analyses of surgery (+/‐ radiotherapy) + chemotherapy versus surgery (+/‐ radiotherapy)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011430-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Patient characteristics for trials of surgery + chemotherapy versus surgery and for trials of surgery + radiotherapy + chemotherapy versus surgery + radiotherapy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Characteristic</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgery + CT*</b> </p> <p><b>(n = 4305)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgery</b> </p> <p><b>(n = 4142)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgery + RT** + CT</b> </p> <p><b>(n = 1315)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Surgery + RT</b> </p> <p><b>(n = 1345)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age (years)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1827 (46%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1669 (44%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>692 (53%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>693 (51%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 ‐ 64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>898 (17%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>900 (18%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>270 (20%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>292 (22%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65 ‐ 69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>872 (20%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>878 (21%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>253 (19%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>253 (19%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt;= 70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>593 (14%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>583 (14%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100 (8%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107 (8%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>115 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>112 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sex</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Male</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2948 (68%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2876 (69%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1023 (78%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1062 (79%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Female</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1238 (29%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1149 (28%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>291 (22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>281 (21%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>117 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (&lt; 1%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adenocarcinoma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2257 (52%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2158(52%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>499 (38%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>501 (37%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Squamous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1649 (38%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1587 (38%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>642 (49%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>655 (49%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>386 (9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>391 (9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>172 (13%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>184 (14%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 (&lt; 1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Stage</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>I</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2851 (66%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2772 (67%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14 (1%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>II</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>806 (19%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>793 (19%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>450 (34%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>473 (35%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IIIa</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>586 (14%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>512 (12%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>804 (61%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>801 (60%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IIIb</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42 (1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 (2%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stage III Unspecified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3(&lt;1%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 (0%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 (&lt; 1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17 (1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 (2%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Performance status</b>† </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Good</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3172 (74%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3022 (73%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>948 (72%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>969 (72%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81 (6%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105 (8%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58 (1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 (1%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not supplied</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>961 (22%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>979 (24%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>264 (20%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>255 (19%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Extent of resection</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Complete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4119 (96%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3951 (95%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1097 (83%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1121 (83%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>123 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179 (14%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>186 (14%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66 (1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68 (2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39 (3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38 (3%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Radiotherapy timing</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CT before RT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>941 (72%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>963 (72%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Concomitant CT + RT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>374 (28%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>382 (28%)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>*CT = Chemotherapy</p> <p>**RT = Radiotherapy</p> <p>†Good = 0,1 ECOG/WHO or 100 ‐ 70 Karnofsky; Poor &gt; 2 ECOG/OMS or &lt;= 60 Karnofsky</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Patient characteristics for trials of surgery + chemotherapy versus surgery and for trials of surgery + radiotherapy + chemotherapy versus surgery + radiotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011430/full#CD011430-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011430-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Surgery versus surgery + adjuvant chemotherapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Platinum + vinca alkaloid/etoposide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.84, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Platinum + vinorelbine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1304</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.70, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Platinum + taxane</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.57, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Other platinum regimens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>699</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.72, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Platinum + vinca alkaloid + tegafur and uracil/tegafur</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.67, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Tegafur and uracil/tegafur + other agent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [1.00, 3.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Tegafur and uracil/tegafur</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.64, 0.90]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Surgery versus surgery + adjuvant chemotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011430/references#CD011430-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011430-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Surgery + radiotherapy versus surgery + radiotherapy + adjuvant chemotherapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2660</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.81, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Platinum + vinca alkaloid/etoposide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1770</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.83, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Platinum + vinorelbine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.63, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Other platinum regimen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.65, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Antimetabolic agent only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.45, 2.34]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Surgery + radiotherapy versus surgery + radiotherapy + adjuvant chemotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011430/references#CD011430-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011430&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011430-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011430-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011430-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011430-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD011430-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="pt#CD011430-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011430-note-0010">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011430\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011430\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011430\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011430"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011430\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011430\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011430\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011430\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011430\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011430"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011430\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011430\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011430\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011430"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011430\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011430\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011430\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011430"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=i9CklieH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011430&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011430';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011430/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011430/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011430%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716984898"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011430/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716984902"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011430/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dacdd1bb7f3f1',t:'MTc0MDcxNjk4NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 